Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in J Acquir Immune Defic Syndr

Retrieve available abstracts of 537 articles:
HTML format
Text format



Single Articles


    May 2017
  1. IZZO I, Quiros-Roldan E, Casari S, Gargiulo F, et al
    Characteristics and Outcome of a Cohort of HIV-1 Non-B Subtype-Infected Patients After a 10-Year Follow-up Period: A Single Centre Experience.
    J Acquir Immune Defic Syndr. 2017;75:e23-e24.
    PubMed     Text format    


  2. PATEL RC, Baeten JM, Heffron R, Hong T, et al
    Brief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data.
    J Acquir Immune Defic Syndr. 2017;75:91-96.
    PubMed     Text format     Abstract available


  3. GOOSBY E, Abrams E, Bekker LG, Mushavi A, et al
    Crossing the Finish Line.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S106-S107.
    PubMed     Text format    


  4. VITILLO RJ, Merico F, Levine AS, Buonocore T, et al
    A Comprehensive Response: The Role of Nonstate Actors in the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S99-S105.
    PubMed     Text format     Abstract available


  5. LYONS C, Pillay Y
    Understanding the Role and Impact of Effective Country and Community Leadership in Progress Toward the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S94-S98.
    PubMed     Text format     Abstract available


  6. MATHESON R, Brion S, Sharma A, Dilmitis S, et al
    Realizing the Promise of the Global Plan: Engaging Communities and Promoting the Health and Human Rights of Women Living With HIV.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S86-S93.
    PubMed     Text format     Abstract available


  7. MODI S, Callahan T, Rodrigues J, Kajoka MD, et al
    Overcoming Health System Challenges for Women and Children Living With HIV Through the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S76-S85.
    PubMed     Text format     Abstract available


  8. RADIN AK, Abutu AA, Okwero MA, Adler MR, et al
    Confronting Challenges in Monitoring and Evaluation: Innovation in the Context of the Global Plan Towards the Elimination of New HIV Infections Among Children by 2015 and Keeping Their Mothers Alive.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S66-S75.
    PubMed     Text format     Abstract available


  9. PENAZZATO M, Amzel A, Abrams EJ, Kiragu K, et al
    Pediatric Treatment Scale-Up: The Unfinished Agenda of the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S59-S65.
    PubMed     Text format     Abstract available


  10. ESSAJEE S, Bhairavabhotla R, Penazzato M, Kiragu K, et al
    Scale-up of Early Infant HIV Diagnosis and Improving Access to Pediatric HIV Care in Global Plan Countries: Past and Future Perspectives.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S51-S58.
    PubMed     Text format     Abstract available


  11. KALUA T, Tippett Barr BA, van Oosterhout JJ, Mbori-Ngacha D, et al
    Lessons Learned From Option B+ in the Evolution Toward "Test and Start" From Malawi, Cameroon, and the United Republic of Tanzania.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S43-S50.
    PubMed     Text format     Abstract available


  12. KIRAGU K, Collins L, Von Zinkernagel D, Mushavi A, et al
    Integrating PMTCT Into Maternal, Newborn, and Child Health and Related Services: Experiences From the Global Plan Priority Countries.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S36-S42.
    PubMed     Text format     Abstract available


  13. HAMILTON E, Bossiky B, Ditekemena J, Esiru G, et al
    Using the PMTCT Cascade to Accelerate Achievement of the Global Plan Goals.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S27-S35.
    PubMed     Text format     Abstract available


  14. ABDOOL KARIM Q, Baxter C, Birx D
    Prevention of HIV in Adolescent Girls and Young Women: Key to an AIDS-Free Generation.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S17-S26.
    PubMed     Text format     Abstract available


  15. LUO C, Hirnschall G, Rodrigues J, Romano S, et al
    Translating Technical Support Into Country Action: The Role of the Interagency Task Team on the Prevention and Treatment of HIV Infection in Pregnant Women, Mothers, and Children in the Global Plan Era.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S7-S16.
    PubMed     Text format     Abstract available


  16. HAROZ D, von Zinkernagel D, Kiragu K
    Development and Impact of the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S2-S6.
    PubMed     Text format     Abstract available


    April 2017
  17. ROSENBERG NE, Graybill LA, Wesevich A, McGrath N, et al
    The Impact of Couple HIV Testing and Counseling on Consistent Condom Use among Pregnant Women and their Male Partners: An Observational Study.
    J Acquir Immune Defic Syndr. 2017 Apr 18. doi: 10.1097/QAI.0000000000001398.
    PubMed     Text format     Abstract available


  18. PUHR R, Kumarasamy N, Ly PS, Ng OT, et al
    HIV and Aging: Demographic Change in the Asia-Pacific Region.
    J Acquir Immune Defic Syndr. 2017;74:e146-e148.
    PubMed     Text format    


  19. GWADZ M, Cleland CM, Perlman DC, Hagan H, et al
    Public Health Benefit of Peer-Referral Strategies for Detecting Undiagnosed HIV Infection Among High-Risk Heterosexuals in New York City.
    J Acquir Immune Defic Syndr. 2017;74:499-507.
    PubMed     Text format     Abstract available


  20. KELLY JD, Reid MJ, Lahiff M, Tsai AC, et al
    Community-level HIV stigma as a driver for HIV transmission risk behaviors and sexually transmitted diseases in Sierra Leone: a population-based study.
    J Acquir Immune Defic Syndr. 2017 Apr 12. doi: 10.1097/QAI.0000000000001418.
    PubMed     Text format     Abstract available


  21. NAIKOBA S, Senjovu KD, Mugabe P, McCarthy C, et al
    Improved HIV and TB knowledge and competence among mid-level providers in a cluster-randomized trial of one-on-one mentorship for task-shifting.
    J Acquir Immune Defic Syndr. 2017 Apr 12. doi: 10.1097/QAI.0000000000001378.
    PubMed     Text format     Abstract available


  22. XIA Q, Zhong Y, Wiewel EW, Braunstein SL, et al
    Linkage to Care after HIV Diagnosis in New York City: Better Than We Thought.
    J Acquir Immune Defic Syndr. 2017 Apr 10. doi: 10.1097/QAI.0000000000001419.
    PubMed     Text format    


  23. PERKINS M, Bradley W, Lalani T, Agan B, et al
    Prevalence of Post-Treatment Controller Phenotype is Rare in HIV-infected Persons after Stopping Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001393.
    PubMed     Text format     Abstract available


  24. DUBROW R, Qin L, Lin H, Hernandez-Ramirez RU, et al
    Associations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001394.
    PubMed     Text format     Abstract available


  25. RIDOLFO AL, Oreni L, Vassalini P, Resnati C, et al
    Effect of Legal Status on the Early Treatment Outcomes of Migrants Beginning Combined Antiretroviral Therapy at an Outpatient Clinic in Milan Italy.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001388.
    PubMed     Text format     Abstract available


  26. GUERRI-FERNANDEZ R, Molina-Morant D, Villar-Garcia J, Herrera S, et al
    Bone density, microarchitecture and tissue quality following long-term treatment with tenofovir/emtricitabine or abacavir/lamivudine.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001396.
    PubMed     Text format     Abstract available


  27. MONTEJANO R, Stella-Ascariz N, Monge S, Bernardino JI, et al
    Impact of antiretroviral treatment containing tenofovir difumarate on the telomere length of aviremic HIV-infected patients.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001391.
    PubMed     Text format     Abstract available


  28. CASETTI R, Pinnetti C, Sacchi A, De Simone G, et al
    HIV-specific CD8 T cells producing CCL-4 are associated with worse immune reconstitution during chronic infection.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001392.
    PubMed     Text format     Abstract available


  29. GAIST P, Stirratt MJ
    The Roles of Behavioral and Social Science Research in the Fight against HIV/AIDS: A Functional Framework.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001399.
    PubMed     Text format     Abstract available


  30. MALLAMPATI D, Ford N, Hanaford A, Sugandhi N, et al
    Performance of virological testing for early infant diagnosis: A systematic review.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001387.
    PubMed     Text format     Abstract available


  31. BROWN LB, Ayieko J, Mwangwa F, Owaraganise A, et al
    Predictors of retention in HIV care among youth (15-24) in a universal test-and-treat setting in rural Kenya.
    J Acquir Immune Defic Syndr. 2017 Apr 6. doi: 10.1097/QAI.0000000000001390.
    PubMed     Text format    


  32. SENA AC, Donovan J, Swygard H, Clymore J, et al
    The North Carolina HIV Bridge Counselor Program: outcomes from a statewide level intervention to link and re-engage HIV-infected persons in care in the South.
    J Acquir Immune Defic Syndr. 2017 Apr 6. doi: 10.1097/QAI.0000000000001389.
    PubMed     Text format     Abstract available


  33. PATEL RR, Chan PA, Mena L, Crowley JS, et al
    Time to make the jump: Translating HIV pre-exposure prophylaxis research into real-world public health impact.
    J Acquir Immune Defic Syndr. 2017 Apr 4. doi: 10.1097/QAI.0000000000001386.
    PubMed     Text format    


  34. HOENIGL M, Braun DL, Kouyos R, Gunthard HF, et al
    Evaluation of the Predictive Potential of the Short Acute Retroviral Syndrome Severity Score for HIV-1 Disease Progression in Individuals With Acute HIV Infection.
    J Acquir Immune Defic Syndr. 2017;74:e114-e117.
    PubMed     Text format    


  35. AGSALDA-GARCIA MA, Sithinamsuwan P, Valcour VG, Chalermchai T, et al
    Brief Report: CD14+ Enriched Peripheral Cells Secrete Cytokines Unique to HIV-Associated Neurocognitive Disorders.
    J Acquir Immune Defic Syndr. 2017;74:454-458.
    PubMed     Text format     Abstract available


  36. MARGOLICK JB, Bream JH, Martinez-Maza O, Lopez J, et al
    Frailty and Circulating Markers of Inflammation in HIV+ and HIV- Men in the Multicenter AIDS Cohort Study.
    J Acquir Immune Defic Syndr. 2017;74:407-417.
    PubMed     Text format     Abstract available


  37. CLOUSE K, Vermund SH, Maskew M, Lurie MN, et al
    Mobility and Clinic Switching Among Postpartum Women Considered Lost to HIV Care in South Africa.
    J Acquir Immune Defic Syndr. 2017;74:383-389.
    PubMed     Text format     Abstract available


  38. PASTOR L, Parker E, Carrillo J, Urrea V, et al
    A Cytokine Pattern That Differentiates Preseroconversion From Postseroconversion Phases of Primary HIV Infection.
    J Acquir Immune Defic Syndr. 2017;74:459-466.
    PubMed     Text format     Abstract available


    March 2017
  39. CUNNINGHAM WE, Ford CL, Kinsler JJ, Seiden D, et al
    Effects of a Laboratory Health Information Exchange Intervention on Antiretroviral Therapy Use, Viral Suppression and Racial/Ethnic Disparities.
    J Acquir Immune Defic Syndr. 2017 Mar 25. doi: 10.1097/QAI.0000000000001385.
    PubMed     Text format     Abstract available


  40. IBRAHIM M, Moyo S, Mohammed T, Mupfumi L, et al
    High Sensitivity and Specificity of the Cepheid Xpert(R) HIV-1 Qualitative Point-of-Care Test among Newborns in Botswana.
    J Acquir Immune Defic Syndr. 2017 Mar 24. doi: 10.1097/QAI.0000000000001384.
    PubMed     Text format     Abstract available


  41. KOELSCH KK, Rasmussen TA, Hey-Nguyen WJ, Pearson C, et al
    Impact of allogeneic hematopoietic stem cell transplantation on the HIV reservoir and immune response in three HIV infected individuals.
    J Acquir Immune Defic Syndr. 2017 Mar 24. doi: 10.1097/QAI.0000000000001381.
    PubMed     Text format     Abstract available


  42. SCRIVEN JE, Graham LM, Schutz C, Scriba TJ, et al
    The CSF immune response in HIV-1-associated cryptococcal meningitis: macrophage activation, correlates of disease severity and effect of antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2017 Mar 24. doi: 10.1097/QAI.0000000000001382.
    PubMed     Text format     Abstract available


  43. MADHAVI V, Kulkarni A, Shete A, Lee WS, et al
    Effect of combination antiretroviral therapy on HIV-1-specific antibody-dependent cellular cytotoxicity responses in subtype B- and subtype C-infected cohorts.
    J Acquir Immune Defic Syndr. 2017 Mar 23. doi: 10.1097/QAI.0000000000001380.
    PubMed     Text format     Abstract available


  44. KELESIDIS T, Oda MN, Borja MS, Yee Y, et al
    Predictors of impaired HDL function in HIV-1 infected compared to uninfected individuals.
    J Acquir Immune Defic Syndr. 2017 Mar 23. doi: 10.1097/QAI.0000000000001383.
    PubMed     Text format     Abstract available


  45. ZHOU RH, Guo L, Liu JB, Liu H, et al
    Epigallocatechin gallate inhibits macaque SEVI-mediated enhancement of SIV or SHIV infection.
    J Acquir Immune Defic Syndr. 2017 Mar 22. doi: 10.1097/QAI.0000000000001361.
    PubMed     Text format     Abstract available


  46. SIVAY MV, Li M, Piwowar-Manning E, Zhang Y, et al
    Characterization of HIV seroconverters in a TDF/FTC PrEP study: HPTN 067/ADAPT.
    J Acquir Immune Defic Syndr. 2017 Mar 22. doi: 10.1097/QAI.0000000000001374.
    PubMed     Text format     Abstract available


  47. LEVINE AJ, Martin E, Sacktor N, Munro C, et al
    Predictors and impact of self-reported suboptimal effort on estimates of prevalence of HIV-associated neurocognitive disorders.
    J Acquir Immune Defic Syndr. 2017 Mar 22. doi: 10.1097/QAI.0000000000001371.
    PubMed     Text format     Abstract available


  48. MUKERJI SS, Misra V, Lorenz D, Cervantes-Arslanian AM, et al
    Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-experienced HIV-1 Infected Adults.
    J Acquir Immune Defic Syndr. 2017 Mar 21. doi: 10.1097/QAI.0000000000001362.
    PubMed     Text format     Abstract available


  49. MAHESWARAN H, Petrou S, MacPherson P, Kumwenda F, et al
    Economic costs and health-related quality of life outcomes of HIV treatment following self- and facility-based HIV testing in a cluster randomised trial.
    J Acquir Immune Defic Syndr. 2017 Mar 21. doi: 10.1097/QAI.0000000000001373.
    PubMed     Text format     Abstract available


  50. MORGAN E, Nyaku AN, D'Aquila RT, Schneider JA, et al
    Determinants of HIV phylogenetic clustering in Chicago among young black men who have sex with men from the uConnect cohort.
    J Acquir Immune Defic Syndr. 2017 Mar 20. doi: 10.1097/QAI.0000000000001379.
    PubMed     Text format     Abstract available


  51. MERLIN JS, Westfall AO, Heath SL, Goodin BR, et al
    IL-1beta levels are associated with chronic multisite pain in people living with HIV.
    J Acquir Immune Defic Syndr. 2017 Mar 20. doi: 10.1097/QAI.0000000000001377.
    PubMed     Text format     Abstract available


  52. REID MJ, Baxi SM, Sheira LA, Landay AL, et al
    Higher Body Mass Index is Associated with Greater Proportions of Effector CD8+ T cells Expressing CD57 in Women Living with HIV.
    J Acquir Immune Defic Syndr. 2017 Mar 20. doi: 10.1097/QAI.0000000000001376.
    PubMed     Text format     Abstract available


  53. CEPEDA JA, Solomon SS, Srikrishnan AK, McFall AM, et al
    Injection drug network characteristics are important markers of HIV risk behavior and lack of viral suppression.
    J Acquir Immune Defic Syndr. 2017 Mar 20. doi: 10.1097/QAI.0000000000001372.
    PubMed     Text format     Abstract available


  54. LUI G, Ma RC, Chook P, Wong CK, et al
    Progression of Atherosclerosis in HIV-infected Individuals - Prospective Data from an Asian Cohort.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001358.
    PubMed     Text format     Abstract available


  55. NACHEGA JB, Uthman OA, Mofenson LM, Anderson JR, et al
    Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001359.
    PubMed     Text format     Abstract available


  56. TEERAANANCHAI S, Bunupuradah T, Puthanakit T, Kerr SJ, et al
    First line antiretroviral treatment outcomes and durability in HIV-infectedchildren treatedthrough theuniversal coverage health program in Thailand.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001351.
    PubMed     Text format     Abstract available


  57. COELHO LE, Ribeiro SR, Japiassu AM, Moreira RI, et al
    30-day readmission rates in an HIV-infected cohort from Rio de Janeiro, Brazil.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001352.
    PubMed     Text format     Abstract available


  58. THOMSON KA, Haberer JE, Marzinke M, Mujugira A, et al
    Medication Sharing is Rare among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001356.
    PubMed     Text format     Abstract available


  59. TOMITA A, Vandormael AM, Barnighausen T, de Oliveira T, et al
    Social disequilibrium and the risk of HIV acquisition: A multilevel study in rural KwaZulu-Natal Province, South Africa.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001349.
    PubMed     Text format     Abstract available


  60. KAHN J, Xu J, Kapogiannis BG, Sleasman JW, et al
    Antibody responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001355.
    PubMed     Text format     Abstract available


  61. KASAIE P, Pennington J, Shah MS, Berry SA, et al
    The Impact of Pre-Exposure Prophylaxis Among Men Who Have Sex With Men: An Individual-Based Model.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001354.
    PubMed     Text format     Abstract available


  62. ARRIBAS JR, Thompson M, Sax PE, Haas B, et al
    A Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil fumarate (TDF), Each Coformulated with Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results.
    J Acquir Immune Defic Syndr. 2017 Mar 9. doi: 10.1097/QAI.0000000000001350.
    PubMed     Text format     Abstract available


  63. HALL EW, Ricca AV, Khosropour CM, Sullivan PS, et al
    Capturing HIV incidence among MSM through at-home and self-reported facility-based testing.
    J Acquir Immune Defic Syndr. 2017 Mar 8. doi: 10.1097/QAI.0000000000001338.
    PubMed     Text format    


  64. WOHL DA, Golin CE, Knight K, Gould M, et al
    A Randomized Controlled Trial of an Intervention to Maintain Suppression of HIV Viremia Following Prison Release: The imPACT Trial.
    J Acquir Immune Defic Syndr. 2017 Mar 8. doi: 10.1097/QAI.0000000000001337.
    PubMed     Text format     Abstract available


  65. RAFFI F, Orkin C, Clarke A, Slama L, et al
    Long-term (96-week) Efficacy and Safety After Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) in HIV-infected, Virologically Suppressed Adults.
    J Acquir Immune Defic Syndr. 2017 Mar 6. doi: 10.1097/QAI.0000000000001344.
    PubMed     Text format     Abstract available


  66. LACOMBE K, Fontaine H, Dhiver C, Metivier S, et al
    Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Co-Infected Patients With Advanced Liver Disease in a French Early-Access Cohort.
    J Acquir Immune Defic Syndr. 2017 Mar 6. doi: 10.1097/QAI.0000000000001342.
    PubMed     Text format     Abstract available


  67. VAN HANDEL MM, Brooks JT
    Reply.
    J Acquir Immune Defic Syndr. 2017;74:e84-e85.
    PubMed     Text format    


  68. BOYLES TH, Gatley E, Wasserman S, Meintjes G, et al
    Brief Report: Flow Rate of Cerebrospinal Fluid Through a Spinal Needle Can Accurately Predict Intracranial Pressure in Cryptococcal Meningitis.
    J Acquir Immune Defic Syndr. 2017;74:e64-e66.
    PubMed     Text format     Abstract available


  69. LIEBENBERG LJ, Masson L, Arnold KB, Mckinnon LR, et al
    Genital-Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women.
    J Acquir Immune Defic Syndr. 2017;74:318-325.
    PubMed     Text format     Abstract available


  70. PARSONS JT, Rendina HJ, Lassiter JM, Whitfield TH, et al
    Uptake of HIV Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the United States.
    J Acquir Immune Defic Syndr. 2017;74:285-292.
    PubMed     Text format     Abstract available


    February 2017
  71. CARLUCCI JG, Blevins M, Kipp AM, Lindegren ML, et al
    Tuberculosis Treatment Outcomes among HIV/TB Co-Infected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network.
    J Acquir Immune Defic Syndr. 2017 Feb 20. doi: 10.1097/QAI.0000000000001335.
    PubMed     Text format     Abstract available


  72. HERNANDEZ S, Catalan-Garcia M, Moren C, Garcia-Otero L, et al
    Placental Mitochondrial Toxicity, Oxidative Stress, Apoptosis And Adverse Perinatal Outcomes In Hiv-Pregnancies Under Antiretroviral Treatment Containing Zidovudine.
    J Acquir Immune Defic Syndr. 2017 Feb 20. doi: 10.1097/QAI.0000000000001334.
    PubMed     Text format     Abstract available


  73. MUSARANDEGA R, Machekano R, Chideme M, Muchuchuti C, et al
    PMTCT Service Uptake among Adolescents and Adult Women Attending Antenatal Care in Selected Health Facilities in Zimbabwe.
    J Acquir Immune Defic Syndr. 2017 Feb 20. doi: 10.1097/QAI.0000000000001327.
    PubMed     Text format     Abstract available


  74. RAY N, Li T, Lin Z, Protack T, et al
    The second-generation maturation inhibitor GSK3532795 maintains potent activity toward HIV protease inhibitor-resistant clinical isolates.
    J Acquir Immune Defic Syndr. 2017 Feb 20. doi: 10.1097/QAI.0000000000001304.
    PubMed     Text format     Abstract available


  75. HELMUT A, Dillingham R, Hogg RS, Jaworsky D, et al
    The Continuum of HIV Care in Rural Communities in the United States and Canada: What Is Known and Future Research Directions.
    J Acquir Immune Defic Syndr. 2017 Feb 16. doi: 10.1097/QAI.0000000000001329.
    PubMed     Text format     Abstract available


  76. XIA Q, Sun X, Wiewel EW, Torian LV, et al
    HIV Prevalence and the Prevalence of Unsuppressed HIV in New York City, 2010-2014.
    J Acquir Immune Defic Syndr. 2017 Feb 14. doi: 10.1097/QAI.0000000000001311.
    PubMed     Text format     Abstract available


  77. SINGH D, Ghate M, Godbole S, Kulkarni S, et al
    CD1d restricted Natural killer T cells are preserved in Indian long term non progressors (LTNPs).
    J Acquir Immune Defic Syndr. 2017 Feb 14. doi: 10.1097/QAI.0000000000001322.
    PubMed     Text format     Abstract available


  78. MACATANGAY BJ, Yang M, Sun X, Morton J, et al
    Changes in Levels of Inflammation Following Antiretroviral Treatment During Early HIV Infection in ACTG A5217.
    J Acquir Immune Defic Syndr. 2017 Feb 14. doi: 10.1097/QAI.0000000000001320.
    PubMed     Text format     Abstract available


  79. BRUNET L, Napravnik S, Heine AD, Leone PA, et al
    Longitudinal opioid use among HIV-infected patients, 2000 to 2014.
    J Acquir Immune Defic Syndr. 2017 Feb 14. doi: 10.1097/QAI.0000000000001321.
    PubMed     Text format     Abstract available


  80. HAALAND RE, Holder A, Pau CP, Swaims-Kohlmeier A, et al
    Levels of intracellular phosphorylated tenofovir and emtricitabine correlate with natural substrate concentrations in peripheral blood mononuclear cells of persons prescribed daily oral TruvadaTM for HIV pre-exposure prophylaxis.
    J Acquir Immune Defic Syndr. 2017 Feb 14. doi: 10.1097/QAI.0000000000001324.
    PubMed     Text format    


  81. GALLANT JE, Thompson M, DeJesus E, Voskuhl GW, et al
    Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults.
    J Acquir Immune Defic Syndr. 2017 Feb 8. doi: 10.1097/QAI.0000000000001306.
    PubMed     Text format     Abstract available


  82. GIRARD A, Jelicic K, Van Ryk D, Rochereau N, et al
    The neutralizing and targeting properties of a new set of alpha4beta7-specific antibodies are influenced by their isotype.
    J Acquir Immune Defic Syndr. 2017 Feb 7. doi: 10.1097/QAI.0000000000001307.
    PubMed     Text format     Abstract available


  83. KESSING CF, Spudich S, Valcour V, Cartwright P, et al
    High Number of Activated CD8+ T Cells Targeting HIV Antigens are Present in Cerebrospinal Fluid in Acute HIV Infection.
    J Acquir Immune Defic Syndr. 2017 Feb 7. doi: 10.1097/QAI.0000000000001301.
    PubMed     Text format     Abstract available


  84. O'NEILL TJ, Raboud JM, Tinmouth J, Rourke SB, et al
    Gastrointestinal Symptom Distress is Associated with Worse Mental and Physical Health Related Quality of Life.
    J Acquir Immune Defic Syndr. 2017 Feb 7. doi: 10.1097/QAI.0000000000001309.
    PubMed     Text format     Abstract available


  85. TENFORDE MW, Yadav A, Dowdy DW, Gupte N, et al
    Vitamin A and D deficiencies associated with incident tuberculosis in HIV-infected patients initiating antiretroviral therapy in multinational case-cohort study.
    J Acquir Immune Defic Syndr. 2017 Feb 6. doi: 10.1097/QAI.0000000000001308.
    PubMed     Text format     Abstract available


  86. BRAHMBHATT H, Boivin M, Ssempijja V, Kagaayi J, et al
    Impact of HIV and Atiretroviral Therapy on Neurocognitive Outcomes Among School Aged Children.
    J Acquir Immune Defic Syndr. 2017 Feb 6. doi: 10.1097/QAI.0000000000001305.
    PubMed     Text format     Abstract available


  87. LYONS C, Ketende S, Drame F, Grosso A, et al
    Physical and sexual violence affecting female sex workers in Abidjan, Cote d'Ivoire: Prevalence, and the relationship between violence, the work environment, HIV and access to health services.
    J Acquir Immune Defic Syndr. 2017 Feb 6. doi: 10.1097/QAI.0000000000001310.
    PubMed     Text format     Abstract available


  88. WOHL AR, Ludwig-Barron N, Dierst-Davies R, Kulkarni S, et al
    Project Engage: Snowball Sampling and Direct Recruitment to Identify and Link Hard-to-Reach HIV-Infected Persons who are Out of Care.
    J Acquir Immune Defic Syndr. 2017 Feb 6. doi: 10.1097/QAI.0000000000001312.
    PubMed     Text format     Abstract available


  89. YOUNG SD, Yu W, Wang W
    Toward Automating HIV Identification: Machine Learning for Rapid Identification of HIV-Related Social Media Data.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S128-S131.
    PubMed     Text format     Abstract available


  90. SENN TE, Braksmajer A, Coury-Doniger P, Urban MA, et al
    Development and Preliminary Pilot Testing of a Peer Support Text Messaging Intervention for HIV-Infected Black Men Who Have Sex With Men.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S121-S127.
    PubMed     Text format     Abstract available


  91. COLASANTI J, Stahl N, Farber EW, Del Rio C, et al
    An Exploratory Study to Assess Individual and Structural Level Barriers Associated With Poor Retention and Re-engagement in Care Among Persons Living With HIV/AIDS.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S113-S120.
    PubMed     Text format     Abstract available


  92. DOLWICK GRIEB SM, Flores-Miller A, Page KR
    inverted exclamation markSolo Se Vive Una Vez! (You Only Live Once): A Pilot Evaluation of Individually Tailored Video Modules Aiming to Increase HIV Testing Among Foreign-Born Latino Men.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S104-S112.
    PubMed     Text format     Abstract available


  93. CASTEL AD, Kuo I, Mikre M, Young T, et al
    Feasibility of Using HIV Care-Continuum Outcomes to Identify Geographic Areas for Targeted HIV Testing.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S96-S103.
    PubMed     Text format     Abstract available


  94. POWERS KA, Samoff E, Weaver MA, Sampson LA, et al
    Longitudinal HIV Care Trajectories in North Carolina.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S88-S95.
    PubMed     Text format     Abstract available


  95. DOMBROWSKI JC, Bove J, Roscoe JC, Harvill J, et al
    "Out of Care" HIV Case Investigations: A Collaborative Analysis Across 6 States in the Northwest US.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S81-S87.
    PubMed     Text format     Abstract available


  96. GREENBERG AE, Gordon CM, Purcell DW
    Promotion of Research on the HIV Continuum of Care in the United States: The CFAR HIV Continuum of Care/ECHPP Working Group.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S75-S80.
    PubMed     Text format    


  97. SCHNELL KM, Atta MG, Fine DM, Zook K, et al
    Longitudinal assessment of proximal tubular dysfunction in HIV seropositive and seronegative persons: correlates and implications.
    J Acquir Immune Defic Syndr. 2017 Feb 1. doi: 10.1097/QAI.0000000000001302.
    PubMed     Text format     Abstract available


    January 2017
  98. GOEIEMAN BJ, Firnhaber CS, Jong E, Michelow P, et al
    Prevalence Of Anal Hpv And Anal Dysplasia In Hiv-Infected Women From Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2017 Jan 30. doi: 10.1097/QAI.0000000000001300.
    PubMed     Text format     Abstract available


  99. LACOURSE SM, Cranmer LM, Matemo D, Kinuthia J, et al
    Effect of pregnancy on interferon gamma release-assay and tuberculin skin test detection of latent TB infection among HIV-infected women in a high burden setting.
    J Acquir Immune Defic Syndr. 2017 Jan 30. doi: 10.1097/QAI.0000000000001298.
    PubMed     Text format     Abstract available


  100. RUBIN LH, Phan KL, Keating SM, Weber KM, et al
    Low dose hydrocortisone has acute enhancing effects on verbal learning in HIV-infected men.
    J Acquir Immune Defic Syndr. 2017 Jan 30. doi: 10.1097/QAI.0000000000001303.
    PubMed     Text format     Abstract available


  101. FELSEN UR, Cunningham CO, Heo M, Futterman DC, et al
    An expanded HIV testing strategy leveraging the electronic medical record uncovers undiagnosed infection among hospitalized patients.
    J Acquir Immune Defic Syndr. 2017 Jan 30. doi: 10.1097/QAI.0000000000001299.
    PubMed     Text format     Abstract available


  102. WALKER JA, Miller AD, Burdo TH, McGrath MS, et al
    Direct Targeting of Macrophages with Methylglyoxal-Bis-Guanylhydrazone Decreases SIV-Associated Cardiovascular Inflammation and Pathology.
    J Acquir Immune Defic Syndr. 2017 Jan 30. doi: 10.1097/QAI.0000000000001297.
    PubMed     Text format     Abstract available


  103. DE LA MATA NL, Ly PS, Van Nguyen K, Merati TP, et al
    Loss to follow-up trends in HIV-positive patients receiving antiretroviral treatment in Asia from 2003 to 2013.
    J Acquir Immune Defic Syndr. 2017 Jan 25. doi: 10.1097/QAI.0000000000001293.
    PubMed     Text format     Abstract available


  104. SAPHONN V, Fujita M, Samreth S, Chan S, et al
    Cluster of HIV Infections Associated with Unsafe Injection Practices in a Rural Village in Cambodia.
    J Acquir Immune Defic Syndr. 2017 Jan 25. doi: 10.1097/QAI.0000000000001295.
    PubMed     Text format    


  105. SANFORD R, Fernandez Cruz AL, Scott SC, Mayo NE, et al
    Regionally Specific Brain Volumetric and Cortical Thickness Changes in HIV-infected Patients in the HAART era.
    J Acquir Immune Defic Syndr. 2017 Jan 25. doi: 10.1097/QAI.0000000000001294.
    PubMed     Text format     Abstract available


  106. KITYO C, Thompson J, Nankya I, Hoppe A, et al
    HIV drug resistance mutations in non-B subtypes after prolonged virological failure on NNRTI-based first-line regimens in sub-Saharan Africa.
    J Acquir Immune Defic Syndr. 2017 Jan 25. doi: 10.1097/QAI.0000000000001285.
    PubMed     Text format     Abstract available


  107. LAU E, Brophy J, Samson L, Kakkar F, et al
    Nevirapine Pharmacokinetics and Safety in Neonates Receiving Combination Antiretroviral Therapy for Prevention of Vertical HIV Transmission.
    J Acquir Immune Defic Syndr. 2017 Jan 20. doi: 10.1097/QAI.0000000000001291.
    PubMed     Text format     Abstract available


  108. BEIMA-SOFIE KM, Brandt L, Hamunime N, Shepard M, et al
    Pediatric HIV disclosure intervention improves knowledge and clinical outcomes in HIV-infected children in Namibia.
    J Acquir Immune Defic Syndr. 2017 Jan 20. doi: 10.1097/QAI.0000000000001290.
    PubMed     Text format     Abstract available


  109. COUDERC C, Keita BD, Anoma C, Wade AS, et al
    Is PrEP needed for MSM in West Africa? HIV incidence in a prospective multi-country cohort.
    J Acquir Immune Defic Syndr. 2017 Jan 18. doi: 10.1097/QAI.0000000000001288.
    PubMed     Text format    


  110. MASIA M, Padilla S, Fernandez M, Barber X, et al
    Contribution of oxidative stress to non-AIDS events in HIV-infected patients.
    J Acquir Immune Defic Syndr. 2017 Jan 18. doi: 10.1097/QAI.0000000000001287.
    PubMed     Text format     Abstract available


  111. WOLDESENBET S, Jackson DJ, Lombard CJ, Dinh TH, et al
    Structural Level Differences in the Mother-to-Child HIV Transmission Rate in South Africa: A Multilevel Assessment of Individual-, Health facility-, and Provincial- Level Predictors of Infant HIV Transmission.
    J Acquir Immune Defic Syndr. 2017 Jan 18. doi: 10.1097/QAI.0000000000001289.
    PubMed     Text format     Abstract available


  112. OKUKU F, Krantz EM, Kafeero J, Kamya MR, et al
    Evaluation of a predictive staging model for HIV-associated Kaposi sarcoma in Uganda.
    J Acquir Immune Defic Syndr. 2017 Jan 18. doi: 10.1097/QAI.0000000000001286.
    PubMed     Text format     Abstract available


  113. TUMINO N, Bilotta MT, Pinnetti C, Ammassari A, et al
    Granulocytic Myeloid Derived Suppressor Cells increased in early phases of primary HIV infection depending on TRAIL plasma level.
    J Acquir Immune Defic Syndr. 2017 Jan 2. doi: 10.1097/QAI.0000000000001283.
    PubMed     Text format     Abstract available


  114. ORR N, Hajiyiannis H, Myers L, Makhubele MB, et al
    Development of a National Campaign Addressing South African Men's Fears About HIV Counseling and Testing and Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S69-S73.
    PubMed     Text format     Abstract available


  115. KERRIGAN D, Mbwambo J, Likindikoki S, Beckham S, et al
    Project Shikamana: Baseline Findings From a Community Empowerment-Based Combination HIV Prevention Trial Among Female Sex Workers in Iringa, Tanzania.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S60-S68.
    PubMed     Text format     Abstract available


  116. LYONS CE, Ketende S, Diouf D, Drame FM, et al
    Potential Impact of Integrated Stigma Mitigation Interventions in Improving HIV/AIDS Service Delivery and Uptake for Key Populations in Senegal.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S52-S59.
    PubMed     Text format     Abstract available


  117. LIPPMAN SA, Neilands TB, MacPhail C, Peacock D, et al
    Community Mobilization for HIV Testing Uptake: Results From a Community Randomized Trial of a Theory-Based Intervention in Rural South Africa.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S44-S51.
    PubMed     Text format     Abstract available


  118. HIRSCH-MOVERMAN Y, Daftary A, Yuengling KA, Saito S, et al
    Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient-Provider Communication in the START Study.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S37-S43.
    PubMed     Text format     Abstract available


  119. SUTTON R, Lahuerta M, Abacassamo F, Ahoua L, et al
    Feasibility and Acceptability of Health Communication Interventions Within a Combination Intervention Strategy for Improving Linkage and Retention in HIV Care in Mozambique.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S29-S36.
    PubMed     Text format     Abstract available


  120. MABUTO T, Charalambous S, Hoffmann CJ
    Effective Interpersonal Health Communication for Linkage to Care After HIV Diagnosis in South Africa.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S23-S28.
    PubMed     Text format     Abstract available


  121. MORTON JF, Celum C, Njoroge J, Nakyanzi A, et al
    Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S15-S22.
    PubMed     Text format     Abstract available


  122. BABALOLA S, Van Lith LM, Mallalieu EC, Packman ZR, et al
    A Framework for Health Communication Across the HIV Treatment Continuum.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S5-S14.
    PubMed     Text format     Abstract available


  123. VERMUND SH, Mallalieu EC, Van Lith LM, Struthers HE, et al
    Health Communication and the HIV Continuum of Care.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S1-S4.
    PubMed     Text format     Abstract available


  124. SEGHATOL-ESLAMI VC, Dark HE, Raper JL, Mugavero MJ, et al
    Brief Report: Interpersonal and Intrapersonal Factors as Parallel Independent Mediators in the Association Between Internalized HIV Stigma and ART Adherence.
    J Acquir Immune Defic Syndr. 2017;74:e18-e22.
    PubMed     Text format     Abstract available


  125. ROSENBERG MS, Gomez-Olive FX, Rohr JK, Houle BC, et al
    Sexual Behaviors and HIV Status: A Population-Based Study Among Older Adults in Rural South Africa.
    J Acquir Immune Defic Syndr. 2017;74:e9-e17.
    PubMed     Text format     Abstract available


  126. ORR N, Hajiyiannis H, Myers L, Makhubele MB, et al
    Development of a National Campaign Addressing South African Men's Fears About HIV Counseling and Testing and Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S69-S73.
    PubMed     Text format     Abstract available


  127. KERRIGAN D, Mbwambo J, Likindikoki S, Beckham S, et al
    Project Shikamana: Baseline Findings From a Community Empowerment-Based Combination HIV Prevention Trial Among Female Sex Workers in Iringa, Tanzania.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S60-S68.
    PubMed     Text format     Abstract available


  128. LYONS CE, Ketende S, Diouf D, Drame FM, et al
    Potential Impact of Integrated Stigma Mitigation Interventions in Improving HIV/AIDS Service Delivery and Uptake for Key Populations in Senegal.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S52-S59.
    PubMed     Text format     Abstract available


  129. LIPPMAN SA, Neilands TB, MacPhail C, Peacock D, et al
    Community Mobilization for HIV Testing Uptake: Results From a Community Randomized Trial of a Theory-Based Intervention in Rural South Africa.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S44-S51.
    PubMed     Text format     Abstract available


  130. HIRSCH-MOVERMAN Y, Daftary A, Yuengling KA, Saito S, et al
    Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient-Provider Communication in the START Study.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S37-S43.
    PubMed     Text format     Abstract available


  131. SUTTON R, Lahuerta M, Abacassamo F, Ahoua L, et al
    Feasibility and Acceptability of Health Communication Interventions Within a Combination Intervention Strategy for Improving Linkage and Retention in HIV Care in Mozambique.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S29-S36.
    PubMed     Text format     Abstract available


  132. MABUTO T, Charalambous S, Hoffmann CJ
    Effective Interpersonal Health Communication for Linkage to Care After HIV Diagnosis in South Africa.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S23-S28.
    PubMed     Text format     Abstract available


  133. MORTON JF, Celum C, Njoroge J, Nakyanzi A, et al
    Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S15-S22.
    PubMed     Text format     Abstract available


  134. BABALOLA S, Van Lith LM, Mallalieu EC, Packman ZR, et al
    A Framework for Health Communication Across the HIV Treatment Continuum.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S5-S14.
    PubMed     Text format     Abstract available


  135. VERMUND SH, Mallalieu EC, Van Lith LM, Struthers HE, et al
    Health Communication and the HIV Continuum of Care.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S1-S4.
    PubMed     Text format     Abstract available


    December 2016
  136. BASSETT IV, Coleman SM, Giddy J, MFamMed, et al
    Barriers to care and 1-year mortality among newly-diagnosed HIV-infected people in Durban, South Africa.
    J Acquir Immune Defic Syndr. 2016 Dec 30. doi: 10.1097/QAI.0000000000001277.
    PubMed     Text format     Abstract available


  137. GOYETTE MS, Wilson KS, Deya R, Masese LN, et al
    Association between menopause and unprotected sex in high-risk HIV-positive women in Mombasa, Kenya.
    J Acquir Immune Defic Syndr. 2016 Dec 30. doi: 10.1097/QAI.0000000000001282.
    PubMed     Text format     Abstract available


  138. HILEMAN CO, Tangpricha V, Sattar A, McComsey GA, et al
    Baseline vitamin D deficiency decreases the effectiveness of statins in HIV-infected adults on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2016 Dec 29. doi: 10.1097/QAI.0000000000001281.
    PubMed     Text format     Abstract available


  139. KILLIAN MS, Fujimura SH, Sudhagoni RG
    Increased Expression of the Type I Interferon Receptor on CD4+ T Lymphocytes in HIV-1 Infected Individuals.
    J Acquir Immune Defic Syndr. 2016 Dec 22. doi: 10.1097/QAI.0000000000001280.
    PubMed     Text format     Abstract available


  140. WEINBERGER AH, Smith PH, Funk AP, Rabin S, et al
    Gender differences in tobacco use among persons living with HIV/AIDS: A systematic review and meta-analysis.
    J Acquir Immune Defic Syndr. 2016 Dec 20. doi: 10.1097/QAI.0000000000001279.
    PubMed     Text format     Abstract available


  141. WEISER J, Brooks JT, Skarbinski J, West BT, et al
    Barriers to Universal Prescribing of Antiretroviral Therapy by HIV Care Providers in the United States, 2013-2014.
    J Acquir Immune Defic Syndr. 2016 Dec 17. doi: 10.1097/QAI.0000000000001276.
    PubMed     Text format     Abstract available


  142. SCHMITZ ME, Agolory S, Junghae M, Broyles LN, et al
    Field evaluation of Dried Blood Spots for HIV-1 viral load monitoring in adults and children receiving antiretroviral treatment in Kenya: Implications for scale-up in resource-limited settings.
    J Acquir Immune Defic Syndr. 2016 Dec 17. doi: 10.1097/QAI.0000000000001275.
    PubMed     Text format     Abstract available


  143. HOTTON AL, Weber KM, Hershow RC, Anastos K, et al
    Prevalence and predictors of hospitalizations among HIV-Infected and at-risk HIV-Uninfected Women.
    J Acquir Immune Defic Syndr. 2016 Dec 17. doi: 10.1097/QAI.0000000000001278.
    PubMed     Text format     Abstract available


  144. LANE T, Osmand T, Marr A, Struthers H, et al
    Brief Report: High HIV Incidence in a South African Community of Men Who Have Sex With Men: Results From the Mpumalanga Men's Study, 2012-2015.
    J Acquir Immune Defic Syndr. 2016;73:609-611.
    PubMed     Text format     Abstract available


  145. MARCUS JL, Hurley LB, Hare CB, Nguyen DP, et al
    Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.
    J Acquir Immune Defic Syndr. 2016;73:540-546.
    PubMed     Text format     Abstract available


  146. GILLIS J, Loutfy M, Bayoumi AM, Antoniou T, et al
    A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2016;73:531-539.
    PubMed     Text format     Abstract available


  147. BOCK P, James A, Nikuze A, Peton N, et al
    Baseline CD4 Count and Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis.
    J Acquir Immune Defic Syndr. 2016;73:514-521.
    PubMed     Text format     Abstract available


  148. WAGNER AD, Mugo C, Njuguna IN, Maleche-Obimbo E, et al
    Implementation and Operational Research: Active Referral of Children of HIV-Positive Adults Reveals High Prevalence of Undiagnosed HIV.
    J Acquir Immune Defic Syndr. 2016;73:e83-e89.
    PubMed     Text format     Abstract available


  149. HANSCOM B, Janes HE, Guarino PD, Huang Y, et al
    Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current Evidence.
    J Acquir Immune Defic Syndr. 2016;73:606-608.
    PubMed     Text format     Abstract available


  150. MOORE CL, Grulich AE, Prestage G, Gidding HF, et al
    Hospitalization for Anxiety and Mood Disorders in HIV-Infected and -Uninfected Gay and Bisexual Men.
    J Acquir Immune Defic Syndr. 2016;73:589-597.
    PubMed     Text format     Abstract available


  151. DAVIS NL, Miller WC, Hudgens MG, Chasela CS, et al
    Maternal and Breastmilk Viral Load: Impacts of Adherence on Peripartum HIV Infections Averted-The Breastfeeding, Antiretrovirals, and Nutrition Study.
    J Acquir Immune Defic Syndr. 2016;73:572-580.
    PubMed     Text format     Abstract available


  152. GAMELL A, Glass TR, Luwanda LB, Mapesi H, et al
    Implementation and Operational Research: An Integrated and Comprehensive Service Delivery Model to Improve Pediatric and Maternal HIV Care in Rural Africa.
    J Acquir Immune Defic Syndr. 2016;73:e67-e75.
    PubMed     Text format     Abstract available


  153. PECK RN, Wang RJ, Mtui G, Smart L, et al
    Linkage to Primary Care and Survival After Hospital Discharge for HIV-Infected Adults in Tanzania: A Prospective Cohort Study.
    J Acquir Immune Defic Syndr. 2016;73:522-530.
    PubMed     Text format     Abstract available


  154. VOGT F, Rehman AM, Kranzer K, Nyathi M, et al
    Relationship between time to initiation of antiretroviral therapy and treatment outcomes: a cohort analysis of ART eligible adolescents in Zimbabwe.
    J Acquir Immune Defic Syndr. 2016 Dec 15. doi: 10.1097/QAI.0000000000001274.
    PubMed     Text format     Abstract available


  155. CATALDO F, Chiwaula L, Nkhata M, van Lettow M, et al
    Exploring the experiences of women and health care workers in the context of PMTCT Option B Plus in Malawi.
    J Acquir Immune Defic Syndr. 2016 Dec 9. doi: 10.1097/QAI.0000000000001273.
    PubMed     Text format     Abstract available


  156. LUCIA P, Erica P, Jorge C, Victor U, et al
    A cytokine pattern that differentiates pre- from post- seroconversion phases of primary HIV infection.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  157. FETTIPLACE A, Stainsby C, Winston A, Givens N, et al
    Psychiatric Symptoms in Patients Receiving Dolutegravir.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  158. NAGAO A, Hanabusa H
    The impact of ledipasvir/sofosbuvir on HIV-positive and HIV-negative Japanese hemophilia patients with 1, 4, and mixed-genotype HCV.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  159. DEREN S, Cleland CM, Lee H, Mehandru S, et al
    The Relationship Between Injection Drug Use Risk Behaviors and Markers of Immune Activation.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  160. KENDALL CE, Chalifoux M, Manuel D, Reinhard R, et al
    A population-based study of care at the end of life among people with HIV in Ontario from 2010 to 2013.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  161. FORD D, Muzambi M, Nkhata MJ, Abongomera G, et al
    Implementation of antiretroviral therapy for life in pregnant/breastfeeding HIV+ women (Option B+) alongside rollout and changing guidelines for ART initiation in rural Zimbabwe: the Lablite Project experience.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  162. KHOSROPOUR CM, Dombrowski JC, Kerani RP, Katz DA, et al
    Changes in Condomless Sex and Serosorting Among Men Who Have Sex With Men After HIV Diagnosis.
    J Acquir Immune Defic Syndr. 2016;73:475-481.
    PubMed     Text format     Abstract available


  163. CHIU A, Modi S, Rivadeneira ED, Koumans EH, et al
    Optimizing Infant HIV Diagnosis in Resource-Limited Settings: Modeling the Impact of HIV DNA PCR Testing at Birth.
    J Acquir Immune Defic Syndr. 2016;73:454-462.
    PubMed     Text format     Abstract available


  164. SHARMA A, Ma Y, Scherzer R, Wheeler AL, et al
    Brief Report: Association of Adipokines With Bone Mineral Density in HIV-Infected and HIV-Uninfected Women.
    J Acquir Immune Defic Syndr. 2016;73:433-437.
    PubMed     Text format     Abstract available


  165. PELTENBURG NC, Leers MP, Bakker JA, Lowe SH, et al
    Inosine Triphosphate Pyrophosphohydrolase Expression: Decreased in Leukocytes of HIV-Infected Patients Using Combination Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2016;73:390-395.
    PubMed     Text format     Abstract available


  166. SONG R, Pace C, Seaman MS, Fang Q, et al
    Distinct HIV-1 Neutralization Potency Profiles of Ibalizumab-Based Bispecific Antibodies.
    J Acquir Immune Defic Syndr. 2016;73:365-373.
    PubMed     Text format     Abstract available


  167. DIERKS P, Wroblewski R, Eberhard JM, Martrus G, et al
    Increased frequency of CD39+ CD56 bright Natural Killer cells in HIV-1 infection correlates with immune activation and disease progression.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  168. COWAN FM, Davey C, Fearon E, Mushati P, et al
    The HIV care cascade among female sex workers in Zimbabwe: results of a population-based survey from the Sisters Antiretroviral therapy Programme for Prevention of HIV, an Integrated Response (SAPPH-IRe) Trial.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


    November 2016
  169. VAN HANDEL MM, Brooks JT
    Understanding local context is necessary for HIV and HCV prevention planning.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  170. WOMACK JA, Murphy TE, Bathulapalli H, Akgun KM, et al
    Sleep Disturbance Among HIV Infected and Uninfected Veterans.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  171. MARZEL A, Heinrich H, Schilliger L, Fehr JS, et al
    Prescription of Post-Exposure Prophylaxis for HIV-1 in the emergency room: Correct transmission risk assessment remains challenging.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  172. ABDEL-HAMEED EA, Rouster SD, Zhang X, Chen J, et al
    Characterization of HCV NS3 Protease Variants in HCV/HIV Coinfected Patients by Ultra-deep Sequence Analysis: Relationship to Hepatic Fibrosis.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  173. PARSONS JT, Rendina HJ, Lassiter JM, Whitfield TH, et al
    Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States: The Motivational PrEP Cascade.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  174. CHAGOMERANA MB, Miller WC, Pence BW, Hosseinipour MC, et al
    PMTCT Option B+ does not increase preterm birth risk and may prevent extreme prematurity: A retrospective cohort study in Malawi.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  175. CHOW FC, Li Y, Hu Y, Chan J, et al
    Relationship between HIV infection, antiretroviral therapy, inflammatory markers and cerebrovascular endothelial function among adults in urban China.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  176. CAMLIN CS, Ayadi AM, Kwena ZA, McFarland W, et al
    High Mobility and HIV Prevalence among Female Market Traders in East Africa in 2014.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  177. DAVEY DJ, Beymer M, Roberts CP, Bolan RK, et al
    Differences in Risk Behavior and Demographic Factors between Men who have Sex with Men with Acute and Non-Acute Human Immunodeficiency Virus Infection in a Community-Based Testing Program in Los Angeles.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  178. SAKODA ME, Fazeli PL, Ellis RJ, Jeste DV, et al
    Higher cystatin C levels are associated with neurocognitive impairment in older HIV+ adults.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  179. PROTOPOPESCU C, Carrieri MP, Raffi F, Picard O, et al
    Prolonged viral suppression over a 12-year follow-up of HIV-infected patients: the persistent impact of adherence at 4 months after initiation of combined antiretroviral therapy in the ANRS CO8 APROCO-COPILOTE cohort.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  180. MENDOZA C, Barrington C, Donastorg Y, Perez M, et al
    Violence from a Sexual Partner is Significantly Associated with Poor HIV Care and Treatment Outcomes among Female Sex Workers in the Dominican Republic.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  181. KORHONEN C, Srinivasan S, Huang D, Ko DL, et al
    Semen Bacterial Concentrations and HIV-1 RNA Shedding among HIV-1-Seropositive Kenyan Men.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  182. GO VF, Frangakis C, Le Minh N, Ha TV, et al
    Increased survival among HIV-infected PWID receiving a multi-level HIV risk and stigma reduction intervention: results from a randomized controlled trial.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  183. KAMENJU P, Liu E, Hertzmark E, Spiegelman D, et al
    Complementary Feeding and Diarrhea and Respiratory Infection Among HIV-exposed Tanzanian Infants.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  184. TURNER CM, Santos GM, Arayasirikul S, Wilson EC, et al
    Psychosocial predictors of engagement in sexual risk behavior among trans*female youth ages 16 - 24 years in San Francisco.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  185. DOBLECKI-LEWIS S, Liu A, Feaster D, Cohen SE, et al
    Healthcare Access and PrEP Continuation in San Francisco and Miami Following the U.S. PrEP Demo Project.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  186. FIDLER S, Olson AD, Bucher HC, Fox J, et al
    Virological blips and predictors of post treatment viral control after stopping ART started in Primary HIV infection.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  187. BRUZZONE B, Caligiuri P, Nigro N, Arcuri C, et al
    In response to Gueudin et al.: Xpert(R) HIV-1 Viral Load assay and VERSANT(R) HIV-1 RNA 1.5 Assay, a performance comparison.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  188. KOSS CA, Natureeba P, Kwarisiima D, Ogena M, et al
    Viral Suppression and Retention in Care up to 5 Years after Initiation of Lifelong ART during Pregnancy (Option B+) in Rural Uganda.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  189. AL-KINDI SG, Kim CH, Morris SR, Freeman ML, et al
    Elevated Red Cell Distribution Width (RDW) Identifies Elevated Cardiovascular Disease Risk in Patients with HIV infection.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  190. MONTEIRO DE ALMEIDA S, Kamat R, Cherner M, Umlauf A, et al
    Improving detection of HIV-associated cognitive impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  191. VITA S, Lichtner M, Marchetti G, Mascia C, et al
    Soluble CD163 in CMV Infected and Uninfected subjects on Virologically-Suppressive Antiretroviral therapy in the ICONA cohort.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  192. MONTOYA JL, Iudicello J, Fazeli PL, Hong S, et al
    Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated with Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  193. KINUTHIA J, Richardson BA, Drake AL, Matemo D, et al
    Sexual Behavior and Vaginal Practices during Pregnancy and Postpartum: Implications for HIV Prevention Strategies.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  194. FOGEL JM, Clarke W, Kulich M, Piwowar-Manning E, et al
    Antiretroviral drug use in a cross-sectional population survey in Africa: NIMH Project Accept (HPTN 043).
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  195. FOX J, Tiraboschi JM, Herrera C, Else L, et al
    Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis.
    J Acquir Immune Defic Syndr. 2016;73:252-257.
    PubMed     Text format     Abstract available


  196. XIA Q, Lazar R, Bernard MA, McNamee P, et al
    New York City Achieves the UNAIDS 90-90-90 Targets for HIV-Infected Whites but Not Latinos/Hispanics and Blacks.
    J Acquir Immune Defic Syndr. 2016;73:e59-e62.
    PubMed     Text format    


  197. HAINES CF, Fleishman JA, Yehia BR, Lau B, et al
    Closing the Gap in Antiretroviral Initiation and Viral Suppression: Time Trends and Racial Disparities.
    J Acquir Immune Defic Syndr. 2016;73:340-347.
    PubMed     Text format     Abstract available


  198. VAN HANDEL MM, Rose CE, Hallisey EJ, Kolling JL, et al
    County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States.
    J Acquir Immune Defic Syndr. 2016;73:323-331.
    PubMed     Text format     Abstract available


  199. LUDEMA C, Cole SR, Eron JJ Jr, Edmonds A, et al
    Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women's Interagency HIV Study, 2006-2009.
    J Acquir Immune Defic Syndr. 2016;73:307-312.
    PubMed     Text format     Abstract available


  200. KARITA E, Nsanzimana S, Ndagije F, Wall KM, et al
    Implementation and Operational Research: Evolution of Couples' Voluntary Counseling and Testing for HIV in Rwanda: From Research to Public Health Practice.
    J Acquir Immune Defic Syndr. 2016;73:e51-e58.
    PubMed     Text format     Abstract available


  201. SSEMMONDO E, Mwangwa F, Kironde JL, Kwarisiima D, et al
    Implementation and Operational Research: Population-Based Active Tuberculosis Case Finding During Large-Scale Mobile HIV Testing Campaigns in Rural Uganda.
    J Acquir Immune Defic Syndr. 2016;73:e46-e50.
    PubMed     Text format     Abstract available


  202. CHANG W, Chamie G, Mwai D, Clark TD, et al
    Implementation and Operational Research: Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa.
    J Acquir Immune Defic Syndr. 2016;73:e39-e45.
    PubMed     Text format     Abstract available


    October 2016
  203. SCHEIM AI, Bauer GR, Travers R
    HIV-related sexual risk among transgender men who are gay, bisexual, or have sex with men.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  204. TAYLOR N, Kremser I, Auer S, Hoermann G, et al
    Hemeoxygenase-1 as a novel driver in ritonavir-induced insulin resistance in HIV-1-infected patients.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  205. SHEPHERD BE, Rebeiro PF
    Assessing and interpreting the association between continuous covariates and outcomes in observational studies of HIV using splines.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  206. YEN YF, Chen M, Jen I, Lan YC, et al
    Association of HIV and Opportunistic Infections with Incident Stroke: A Nationwide Population-based Cohort Study in Taiwan.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  207. LIEBENBERG LJ, Masson L, Arnold KB, Mckinnon LR, et al
    Genital - Systemic chemokine gradients and the risk of HIV acquisition in women.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  208. CHOI KH, Steward WT, Miege P, Gregorich SE, et al
    Unpacking the Influence of Sexual Stigma on HIV Risk: Results from a Prospective Study of Men Who Have Sex with Men in Beijing, China.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  209. VOGT F, Kalenga L, Lukela J, Salumu F, et al
    Decentralizing ART supply for stable HIV patients to community-based distribution centres: Programme outcomes from an urban context in Kinshasa, DRC.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  210. YOTEBIENG M, Moracco KE, Thirumurthy H, Edmonds A, et al
    Conditional cash transfers improve retention in PMTCT services by mitigating the negative effect of not having money to come to the clinic.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  211. GOMEZ-MORA E, Robert-Hebmann V, Garcia E, Massanella M, et al
    Impaired CD4 T-cell response to autophagy in treated HIV-1-infected individuals.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  212. EATON EF, Hudak K, Muzny CA
    Budgetary Impact of Compliance with STI Screening Guidelines in Persons Living with HIV.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  213. HARRIS RA, Xue X, Selwyn PA
    Housing Stability and Medication Adherence among HIV-Positive Individuals in Antiretroviral Therapy: A Meta-Analysis of Observational Studies in the U.S.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  214. BAXI SM, Scherzer R, Jotwani V, Estrella MM, et al
    Changes in Urinary Biomarkers over 10 Years is Associated with Viral Suppression in a Prospective Cohort of Women Living with HIV.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  215. KOURTIS AP, Wiener J, King CC, Heffron R, et al
    Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-infected African women.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  216. PIRONTI A, Walter H, Pfeifer N, Knops E, et al
    Determination of Phenotypic Resistance Cutoffs from Routine Clinical Data.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  217. HUHN GD, Tebas P, Gallant J, Wilkin T, et al
    A Randomized , Open-label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide plus Darunavir in Treatment-Experienced HIV-1 Infected Adults.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  218. MANHICA I, Bhatt N, Ismael N, Nhavene E, et al
    First report of prevalence of HTLV-1 among HIV-1/2 infected children in Mozambique.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  219. WINSTON A, Stohr W, Antinori A, Amieva H, et al
    Changes in Cognitive Function Over 96 weeks in Naive Patients Randomised to Darunavir-ritonavir plus either Raltegravir or Tenofovir-Emtricitabine: a substudy of the NEAT001/ANRS143 trial.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  220. SATRE DD, Altschuler A, Parthasarathy S, Silverberg MJ, et al
    Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  221. BALLEGAARD V, Ralfkiaer U, Pedersen KK, Hove M, et al
    MicroRNA-210, microRNA-331 and microRNA-7 are differentially regulated in treated HIV-1-infected individuals, and are associated with markers of systemic inflammation.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  222. SHI B, Li J, Shi X, Jia W, et al
    TALEN-mediated knockout of CCR5 confers protection against infection of human immunodeficiency virus.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  223. JOSEPH DAVEY D, Nhavoto JA, Augusto O, Ponce W, et al
    SMSaude: Evaluating Mobile Phone Text Reminders to Improve Retention in HIV Care for Patients on Antiretroviral Therapy in Mozambique.
    J Acquir Immune Defic Syndr. 2016;73:e23-30.
    PubMed     Text format     Abstract available


  224. RANSOME Y, Galea S, Pabayo R, Kawachi I, et al
    Social Capital is Associated With Late HIV Diagnosis: An Ecological Analysis.
    J Acquir Immune Defic Syndr. 2016;73:213-21.
    PubMed     Text format     Abstract available


  225. BASSETT IV, Coleman SM, Giddy J, Bogart LM, et al
    Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South Africa.
    J Acquir Immune Defic Syndr. 2016;73:154-60.
    PubMed     Text format     Abstract available


  226. STIKSRUD B, Lorvik KB, Kvale D, Mollnes TE, et al
    Plasma IP-10 Is Increased in Immunological NonResponders and Associated With Activated Regulatory T Cells and Persisting Low CD4 Counts.
    J Acquir Immune Defic Syndr. 2016;73:138-48.
    PubMed     Text format     Abstract available


    September 2016
  227. LEE SK, Zhou S, Baldoni PL, Spielvogel E, et al
    Quantification of the Latent HIV-1 Reservoir Using Ultra Deep Sequencing and Primer ID In A Viral Outgrowth Assay.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  228. POST FA, Tebas P, Clarke A, Cotte L, et al
    Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  229. BOYLES TH, Gately E, Wasserman S, Meintjes G, et al
    Flow rate of CSF through a spinal needle can accurately predict intracranial pressure in cryptococcal meningitis.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  230. BACON O, Gonzalez R, Andrew E, Potter MB, et al
    Informing Strategies to Build PrEP Capacity among San Francisco Bay Area Clinicians.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  231. THOBAKGALE C, Naidoo K, McKinnon LR, Werner L, et al
    Interleukin 1-beta (IL-1beta) production by innate cells following TLR stimulation correlates with TB recurrence in ART-treated HIV infected patients.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  232. XIA Q, Teixeira-Pinto A, Forgione LA, Wiewel EW, et al
    Estimated HIV Incidence in the United States, 2003-2010.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  233. WAGNER AD, Wachira CM, Njuguna IN, Maleche-Obimbo E, et al
    Active referral of children of HIV-positive adults reveals high prevalence of undiagnosed HIV.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  234. HOSEK S, Rudy B, Landovitz R, Kapogiannis B, et al
    An HIV Pre-Exposure Prophylaxis (PrEP) Demonstration Project and Safety Study for Young MSM.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  235. WESTERCAMP M, Jaoko W, Mehta S, Abuor P, et al
    Changes in Male Circumcision Prevalence and Risk Compensation in the Kisumu, Kenya Population 2008-2013.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  236. YU F, Hao Y, Zhao H, Xiao J, et al
    Distinct Mitochondrial Disturbance in CD4+T and CD8+T Cells from HIV-infected Patients.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  237. DUFF P, Goldenberg S, Deering K, Montaner J, et al
    Barriers to Viral Suppression Among Female Sex Workers: Role of Structural and Intimate Partner Dynamics.
    J Acquir Immune Defic Syndr. 2016;73:83-90.
    PubMed     Text format     Abstract available


  238. KOOIJ KW, Schouten J, Wit FW, van der Valk M, et al
    Difference in Aortic Stiffness Between Treated Middle-Aged HIV Type 1-Infected and Uninfected Individuals Largely Explained by Traditional Cardiovascular Risk Factors, With an Additional Contribution of Prior Advanced Immunodeficiency.
    J Acquir Immune Defic Syndr. 2016;73:55-62.
    PubMed     Text format     Abstract available


  239. BRENNAN AT, Long L, Useem J, Garrison L, et al
    Mortality in the First 3 Months on Antiretroviral Therapy Among HIV-Positive Adults in Low- and Middle-income Countries: A Meta-analysis.
    J Acquir Immune Defic Syndr. 2016;73:1-10.
    PubMed     Text format     Abstract available


  240. PADAYATCHI N, Naidu N, Yende-Zuma N, O'Donnell MR, et al
    Implementation and Operational Research: Clinical Impact of the Xpert MTB/RIF Assay in Patients With Multidrug-Resistant Tuberculosis.
    J Acquir Immune Defic Syndr. 2016;73:e1-7.
    PubMed     Text format     Abstract available


  241. QUISPE CALLA NE, Vicetti Miguel RD, Trout W, Cherpes TL, et al
    HIV and Hormonal Contraception: Bench and Bedside.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  242. RONEN K, McGrath CJ, Langat AC, Kinuthia J, et al
    Gaps in Adolescent Engagement in Antenatal Care and Prevention of Mother-to-Child HIV Transmission Services in Kenya.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  243. GAMELL A, Glass TR, Luwanda LB, Mapesi H, et al
    An Integrated and Comprehensive Service Delivery Model to Improve Pediatric and Maternal HIV Care in Rural Africa.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


    August 2016
  244. PAGANELLA MP, Cohen RA, Harris DR, de Souza Kuchenbecker R, et al
    Association of Dyslipidemia and Glucose Abnormalities with Antiretroviral Treatment in a Cohort of HIV-infected Latin American Children.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  245. FLORIDIA M, Liotta G, Andreotti M, Galluzzo CM, et al
    Serum phosphate and creatinine levels in the first year of life in infants born to HIV-positive mothers receiving tenofovir-based combination regimens during pregnancy and prolonged breastfeeding in an option B+ programme in Malawi.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  246. GUO D, Zhou T, Arainga M, Palandri D, et al
    Creation of a Long-Acting Nanoformulated 2',3'-Dideoxy-3'-Thiacytidine.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  247. HOLLOWAY I, Dougherty R, Gildner J, Beougher SC, et al
    PrEP Uptake, Adherence, and Discontinuation among California YMSM Using Geosocial Networking Applications.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  248. CANOUI E, Noel N, Lecuroux C, Boufassa F, et al
    Strong Ifitm1 Expression In Cd4 T Cells In Hiv Controllers Is Correlated With Immune Activation.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  249. ELOPRE L, Kudroff K, Westfall AO, Overton ET, et al
    The Right People, Right Places, and Right Practices: Disparities in PrEP access among African American Men, Women and MSM in the Deep South.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  250. SHIN SS, Modongo C, Boyd R, Caiphus C, et al
    High Treatment Success Rates among HIV-infected Multidrug-resistant Tuberculosis Patients after Expansion of Antiretroviral Therapy in Botswana, 2006-2013.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  251. CALENDA G, Villegas G, Barnable P, Litterst C, et al
    MZC gel inhibits SHIV-RT and HSV-2 in macaque vaginal mucosa and SHIV-RT in rectal mucosa.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  252. SAAG MS, Westfall AO, Cole SR, Mathews WC, et al
    Factors associated with the selection of initial antiretroviral therapy from 2009 to 2012.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  253. CHETWYND AJ, Samarawickrama A, Vera JH, Bremner SA, et al
    Nanoflow-nanospray mass spectrometry metabolomics reveals disruption of the urinary metabolite profiles of HIV-positive patients on combination antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  254. HANSCOM B, Janes HE, Guarino PD, Huang Y, et al
    Preventing HIV-1 Infection in Women using Oral Pre-Exposure Prophylaxis: A Meta-analysis of Current Evidence.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  255. ESHLEMAN SH, Hudelson SE, Redd AD, Swanstrom R, et al
    Treatment as Prevention: Characterization of partner infections in the HIV Prevention Trials Network 052 trial.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  256. WYNDHAM-THOMAS C, Corbiere V, Selis E, Payen MC, et al
    Immune activation by Mycobacterium tuberculosis in HIV-infected and -uninfected subjects.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  257. THIRUMURTHY H, Masters SH, Rao S, Murray K, et al
    The Effects of Providing Fixed Compensation and Lottery-Based Rewards on Uptake of Medical Male Circumcision in Kenya: A Randomized Trial.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S299-305.
    PubMed     Text format     Abstract available


  258. KAUFMAN ZA, DeCelles J, Bhauti K, Hershow RB, et al
    A Sport-Based Intervention to Increase Uptake of Voluntary Medical Male Circumcision Among Adolescent Male Students: Results From the MCUTS 2 Cluster-Randomized Trial in Bulawayo, Zimbabwe.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S292-8.
    PubMed     Text format     Abstract available


  259. WILSON N, Frade S, Rech D, Friedman W, et al
    Advertising for Demand Creation for Voluntary Medical Male Circumcision.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S288-91.
    PubMed     Text format     Abstract available


  260. BAZANT E, Mahler H, Machaku M, Lemwayi R, et al
    A Randomized Evaluation of a Demand Creation Lottery for Voluntary Medical Male Circumcision Among Adults in Tanzania.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S280-7.
    PubMed     Text format     Abstract available


  261. SEMEERE AS, Castelnuovo B, Bbaale DS, Kiragga AN, et al
    Innovative Demand Creation for Voluntary Medical Male Circumcision Targeting a High Impact Male Population: A Pilot Study Engaging Pregnant Women at Antenatal Clinics in Kampala, Uganda.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S273-9.
    PubMed     Text format     Abstract available


  262. LEIBY K, Connor A, Tsague L, Sapele C, et al
    The Impact of SMS-Based Interventions on VMMC Uptake in Lusaka Province, Zambia: A Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S264-72.
    PubMed     Text format     Abstract available


  263. ZANOLINI A, Bolton C, Lyabola LL, Phiri G, et al
    Feasibility and Effectiveness of a Peer Referral Incentive Intervention to Promote Male Circumcision Uptake in Zambia.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S257-63.
    PubMed     Text format     Abstract available


  264. SINGH JA
    Ethical Issues to Consider in the Design of HIV Prevention Trials Involving Transgender People.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S252-5.
    PubMed     Text format     Abstract available


  265. HUGHES JP, Emel L, Hanscom B, Zangeneh S, et al
    Design Issues in Transgender Studies.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S248-51.
    PubMed     Text format     Abstract available


  266. SISKIND RL, Andrasik M, Karuna ST, Broder GB, et al
    Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials Research.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S243-7.
    PubMed     Text format     Abstract available


  267. REISNER SL, Radix A, Deutsch MB
    Integrated and Gender-Affirming Transgender Clinical Care and Research.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S235-42.
    PubMed     Text format     Abstract available


  268. ANDERSON PL, Reirden D, Castillo-Mancilla J
    Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S230-4.
    PubMed     Text format     Abstract available


  269. GRANT RM, Sevelius JM, Guanira JV, Aguilar JV, et al
    Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S226-9.
    PubMed     Text format     Abstract available


  270. GAROFALO R, Kuhns LM, Reisner SL, Mimiaga MJ, et al
    Behavioral Interventions to Prevent HIV Transmission and Acquisition for Transgender Women: A Critical Review.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S220-5.
    PubMed     Text format     Abstract available


  271. POTEAT T, Scheim A, Xavier J, Reisner S, et al
    Global Epidemiology of HIV Infection and Related Syndemics Affecting Transgender People.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S210-9.
    PubMed     Text format     Abstract available


  272. MAYER KH, Grinsztejn B, El-Sadr WM
    Transgender People and HIV Prevention: What We Know and What We Need to Know, a Call to Action.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S207-9.
    PubMed     Text format     Abstract available


  273. KABAGAMBE EK, Ezeamama AE, Guwatudde D, Campos H, et al
    Plasma n6-fatty acid levels are associated with CD4 cell counts, hospitalization and mortality in HIV-infected patients.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  274. CHAILLON A, Smith DM, Vanpouille C, Lisco A, et al
    HIV Trafficking between Blood and Semen during Early Untreated HIV Infection.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  275. AGUILAR-JIMENEZ W, Villegas-Ospina S, Gonzalez S, Zapata W, et al
    Active and precursor forms of Vitamin D reduce HIV-1 infection in vitro.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  276. SONG R, Hall HI, Green TA, Szwarcwald CL, et al
    Using CD4 Data to Estimate HIV Incidence, Prevalence, and Percent of Undiagnosed Infections in the United States.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  277. NICHOLAS KJ, Flaherty DK, Smith RM, Sather DN, et al
    Chronic HIV-1 infection impairs superantigen-induced activation of peripheral CD4+CXCR5+PD-1+ cells, with relative preservation of recall antigen-specific responses.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  278. HARTLING HJ, Jespersen S, Gaardbo JC, Sambleben C, et al
    Reduced IL-7R T cell expression and increased plasma sCD127 in late presenting HIV-infected individuals.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  279. AARONS GA, Sommerfeld DH, Chi BH, Ezeanolue EE, et al
    Concept Mapping of PMTCT Implementation Challenges and Solutions Across 6 sub-Saharan African Countries in the NIH-PEPFAR PMTCT Implementation Science Alliance.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S202-6.
    PubMed     Text format     Abstract available


  280. CHIBWESHA CJ, Ford CE, Mollan KR, Stringer JS, et al
    Point-of-Care Virologic Testing to Improve Outcomes of HIV-Infected Children in Zambia: A Clinical Trial Protocol.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S197-201.
    PubMed     Text format     Abstract available


  281. MYER L, Phillips TK, Zerbe A, Ronan A, et al
    Optimizing Antiretroviral Therapy (ART) for Maternal and Child Health (MCH): Rationale and Design of the MCH-ART Study.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S189-96.
    PubMed     Text format     Abstract available


  282. NAPUA M, Pfeiffer JT, Chale F, Hoek R, et al
    Option B+ in Mozambique: Formative Research Findings for the Design of a Facility-Level Clustered Randomized Controlled Trial to Improve ART Retention in Antenatal Care.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S181-8.
    PubMed     Text format     Abstract available


  283. SHARMA M, Farquhar C, Ying R, Krakowiak D, et al
    Modeling the Cost-Effectiveness of Home-Based HIV Testing and Education (HOPE) for Pregnant Women and Their Male Partners in Nyanza Province, Kenya.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S174-80.
    PubMed     Text format     Abstract available


  284. KRAKOWIAK D, Kinuthia J, Osoti AO, Asila V, et al
    Home-Based HIV Testing Among Pregnant Couples Increases Partner Testing and Identification of Serodiscordant Partnerships.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S167-73.
    PubMed     Text format     Abstract available


  285. EZEANOLUE EE, Powell BJ, Patel D, Olutola A, et al
    Identifying and Prioritizing Implementation Barriers, Gaps, and Strategies Through the Nigeria Implementation Science Alliance: Getting to Zero in the Prevention of Mother-to-Child Transmission of HIV.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S161-6.
    PubMed     Text format     Abstract available


  286. PHARR JR, Obiefune MC, Ezeanolue CO, Osuji A, et al
    Linkage to Care, Early Infant Diagnosis, and Perinatal Transmission Among Infants Born to HIV-Infected Nigerian Mothers: Evidence From the Healthy Beginning Initiative.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S154-60.
    PubMed     Text format     Abstract available


  287. PRICE JT, Wheeler SB, Stranix-Chibanda L, Hosek SG, et al
    Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S145-53.
    PubMed     Text format     Abstract available


  288. FAYORSEY RN, Chege D, Wang C, Reidy W, et al
    Mother Infant Retention for Health (MIR4Health): Study Design, Adaptations, and Challenges With PMTCT Implementation Science Research.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S137-44.
    PubMed     Text format     Abstract available


  289. REIMERS P, Israel-Ballard K, Spies L, Tanser F, et al
    A Protocol for a Cluster Randomized Trial on the Effect of a "feeding buddy" Program on adherence to the Prevention of Mother-To-Child-Transmission Guidelines in a Rural Area of KwaZulu-Natal, South Africa.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S130-6.
    PubMed     Text format     Abstract available


  290. YOTEBIENG M, Thirumurthy H, Moracco KE, Edmonds A, et al
    Conditional Cash Transfers to Increase Retention in PMTCT Care, Antiretroviral Adherence, and Postpartum Virological Suppression: A Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S124-9.
    PubMed     Text format     Abstract available


  291. BOEHMER A, Audet CM, Blevins M, Gebi UI, et al
    Patient and Provider Satisfaction With a Comprehensive Strategy to Improve Prevention of Mother-to-Child HIV Transmission Services in Rural Nigeria.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S117-23.
    PubMed     Text format     Abstract available


  292. GIMBEL S, Rustagi AS, Robinson J, Kouyate S, et al
    Evaluation of a Systems Analysis and Improvement Approach to Optimize Prevention of Mother-To-Child Transmission of HIV Using the Consolidated Framework for Implementation Research.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S108-16.
    PubMed     Text format     Abstract available


  293. PRASITSUEBSAI W, Teeraananchai S, Singtoroj T, Truong KH, et al
    Treatment Outcomes and Resistance Patterns of Children and Adolescents on Second-Line Antiretroviral Therapy in Asia.
    J Acquir Immune Defic Syndr. 2016;72:380-6.
    PubMed     Text format     Abstract available


  294. BUTLER K, Ritter JM, Ellis S, Morris MR, et al
    A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk.
    J Acquir Immune Defic Syndr. 2016;72:363-71.
    PubMed     Text format     Abstract available


  295. GUST DA, Soud F, Hardnett F, Malotte CK, et al
    Evaluation of sexual risk behavior among study participants in the TDF2 PrEP study among heterosexual adults in Botswana.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  296. HAISSMAN JM, Haugaard AK, Knudsen A, Kristoffersen US, et al
    Marker of endothelial dysfunction asymmetric dimethylarginine is elevated in HIV infection but not associated with sub-clinical atherosclerosis.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  297. DAVIS NL, Miller WC, Hudgens MG, Chasela CS, et al
    Maternal and Breast Milk Viral Load: Impacts of Adherence on Peri-Partum HIV Infections Averted - the BAN Study.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  298. MOORE CL, Grulich AE, Prestage G, Gidding HF, et al
    Hospitalisation for Anxiety and Mood Disorders in HIV-infected and -Uninfected Gay and Bisexual Men.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  299. KEATING SM, Kassanjee R, Lebedeva M, Facente SN, et al
    Performance of the Bio-Rad Geenius HIV1/2 supplemental assay in detecting 'recent' HIV infection and calculating population incidence.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  300. ALFONSO YN, Bishai D, Nantongo A, Kakembo R, et al
    Trends in the Marginal Cost of Male Circumcision in Rural Rakai Uganda.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


    July 2016
  301. CHANG W, Chamie G, Mwai D, Clark TD, et al
    Cost and efficiency of a hybrid mobile multi-disease testing approach with high HIV testing coverage in East Africa.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  302. SSEMMONDO E, Mwangwa F, Kironde JL, Kwarisiima D, et al
    Population-based active TB case finding during large-scale mobile HIV testing campaigns in rural Uganda.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  303. GUHA A, Brier MR, Ortega M, Westerhaus E, et al
    Topographies of cortical and subcortical volume loss in HIV and aging in the cART era.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  304. LELUTIU-WEINBERGER C, Golub SA
    Enhancing PrEP Access for Black and Latino Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  305. AULD AF, Shiraishi RW, Couto A, Mbofana F, et al
    A Decade of Antiretroviral Therapy Scale-up in Mozambique: Evaluation of Outcome Trends and New Models of Service Delivery Among more than 300,000 Patients Enrolled during 2004[FIGURE DASH]2013.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  306. KARITA E, Nsanzimana S, Ndagije F, Wall KM, et al
    Evolution of Couples Voluntary Counseling and Testing for HIV in Rwanda: From Research to Public Health Practice.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  307. FRIEDLAND BA, Hoesley CJ, Plagianos M, Hoskin E, et al
    A First-in-Human Trial of MIV-150 and Zinc Acetate Co-Formulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence and Pharmacodynamics.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  308. ONU CC, Dworkin SL, Ongeri LG, Oyaro P, et al
    Sexual violence against HIV-positive women in the Nyanza region of Kenya: Is condom negotiation an instigator?
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  309. PILCHER CD, Ospina-Norvell C, Dasgupta A, Jones D, et al
    The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a U.S. Public Health Setting.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  310. BENGTSON AM, Pence BW, Gaynes BN, Quinlivan EB, et al
    Improving depression among HIV-infected adults: transporting the effect of a depression treatment intervention to routine care.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  311. TRIPLETTE M, Attia E, Akgun K, Campo M, et al
    The differential impact of emphysema on respiratory symptoms and six-minute walk distance in HIV infection.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  312. BEER L, Bradley H, Mattson CL, Johnson CH, et al
    Trends in racial and ethnic disparities in antiretroviral therapy prescription and viral suppression in the United States, 2009-2013: Trends in disparities in HIV care.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  313. PAN SW, Zhang Z, Li D, Carpiano RM, et al
    Religion and HIV sexual risk among men who have sex with men in China.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  314. SOBIESZCZYK ME, Werner L, Mlisana K, Naicker N, et al
    Metabolic syndrome after HIV acquisition in South African women.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  315. SHRESTHA RK, Farnham PG, Whitham HK, Sansom SL, et al
    Challenges in Estimating Effectiveness of Condom Distribution Campaigns to Prevent HIV Transmission.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  316. YOUSEF KP, Meixenberger K, Smith MR, Somogyi S, et al
    Inferring HIV-1 transmission dynamics in Germany from recently transmitted viruses.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available



  317. The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.
    J Acquir Immune Defic Syndr. 2016;72:e82.
    PubMed     Text format    


  318. DIRIX V, Schepers K, Massinga-Loembe M, Worodria W, et al
    Added Value of Long-Term Cytokine Release Assays to Detect Mycobacterium tuberculosis Infection in HIV-Infected Subjects in Uganda.
    J Acquir Immune Defic Syndr. 2016;72:344-52.
    PubMed     Text format     Abstract available


  319. GIRARD A, Vergnon-Miszczycha D, Depince-Berger AE, Roblin X, et al
    Brief Report: A High Rate of beta7+ Gut-Homing Lymphocytes in HIV-Infected Immunological Nonresponders is Associated With Poor CD4 T-Cell Recovery During Suppressive HAART.
    J Acquir Immune Defic Syndr. 2016;72:259-65.
    PubMed     Text format     Abstract available


    June 2016
  320. SUPERVIE V, Marty L, Lacombe JM, Dray-Spira R, et al
    Looking beyond the cascade of HIV care to end the AIDS epidemic: estimation of the time interval from HIV infection to viral suppression.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  321. CONROY AA, Gamarel KE, Neilands TB, Sauceda JA, et al
    Partner reports of HIV viral suppression predict sexual behavior in serodiscordant male couples.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  322. SAMUEL R, Julian MN, Paredes R, Parboosing R, et al
    HIV-1 Drug resistance by Ultra-deep sequencing following short course Zidovudine, single dose Nevirapine and single dose Tenofovir with Emtricitabine for pMTCT.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  323. CLIFFORD GM, de Vuyst H, Tenet V, Plummer M, et al
    Effect of HIV infection on human papillomavirus types causing invasive cervical cancer in Africa.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  324. PECK RN, Wang RJ, Mtui G, Smart L, et al
    Linkage to primary care and survival after hospital discharge for HIV-infected adults in Tanzania: a prospective cohort study.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  325. SLAVEN JE, Decker BS, Kashuba AD, Atta MG, et al
    Plasma and Intracellular Concentrations in HIV-infected Patients Requiring Hemodialysis Dosed with Tenofovir Disoproxil Fumarate and Emtricitabine: TDF and FTC in HD.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  326. KUNIHOLM MH, O'Brien TR, Prokunina-Olsson L, Augenbraun M, et al
    Association of Hepatitis C Virus Infection With CD4/CD8 Ratio in HIV-Positive Women.
    J Acquir Immune Defic Syndr. 2016;72:162-70.
    PubMed     Text format     Abstract available


  327. SHET A, Nagaraja P, Dixit NM
    Viral decay dynamics and mathematical modeling of treatment response: evidence of lower in vivo fitness of HIV-1 subtype C.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  328. JUDGE CJ, Sandberg JK, Funderburg NT, Sherman KE, et al
    CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapy.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  329. FRAM F, Church F, Sundaram M, Sgaier SK, et al
    Employing Demand-Based Volumetric Forecasting to Identify Potential for and Roles of Devices in Scale-Up of Medical Male Circumcision in Zambia and Zimbabwe.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S83-9.
    PubMed     Text format     Abstract available


  330. MILOVANOVIC M, Taruberekera N, Martinson N, Lebina L, et al
    Perceptions of the PrePex Device Among Men Who Received or Refused PrePex Circumcision and People Accompanying Them.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S78-82.
    PubMed     Text format     Abstract available


  331. MUSIIGE AM, Ashengo TA, Stolarsky G, Dialwa RT, et al
    Participant Experiences and Views of Odor and PrePex Device Removal Pain in a VMMC Pilot Study in Botswana.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S73-7.
    PubMed     Text format     Abstract available


  332. KUFA T, Chetty-Makkan C, Maraisane M, Charalambous S, et al
    Delivering PrePex Medical Male Circumcision Services Through a Mobile Clinic: The Experience From a Pilot Project in North West Province, South Africa.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S69-72.
    PubMed     Text format     Abstract available


  333. MAVHU W, Hatzold K, Ncube G, Xaba S, et al
    Safety and Acceptability of the PrePex Device When Used in Routine Male Circumcision Service Delivery During Active Surveillance in Zimbabwe.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S63-8.
    PubMed     Text format     Abstract available


  334. CUMMINGS B, Necochea E, Ferreira T, Soares B, et al
    Acceptability and Satisfaction Associated With the Introduction of the PrePex Circumcision Device in Maputo, Mozambique.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S56-62.
    PubMed     Text format     Abstract available


  335. SAMUELSON J, Hargreave T, Ridzon R, Farley T, et al
    Innovative Methods of Male Circumcision for HIV Prevention-Getting the Right Evidence.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S5-S12.
    PubMed     Text format     Abstract available


  336. FELDBLUM P, Martinson N, Bvulani B, Taruberekera N, et al
    Safety and Efficacy of the PrePex Male Circumcision Device: Results From Pilot Implementation Studies in Mozambique, South Africa, and Zambia.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S43-8.
    PubMed     Text format     Abstract available


  337. FELDBLUM PJ, Zulu R, Linyama D, Long S, et al
    Randomized Controlled Trial of the ShangRing for Adult Medical Male Circumcision: Safety, Effectiveness, and Acceptability of Using 7 Versus 14 Device Sizes.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S30-5.
    PubMed     Text format     Abstract available


  338. BARONE MA, Li PS, Zulu R, Awori QD, et al
    Men's Understanding of and Experiences During the Postcircumcision Abstinence Period: Results From a Field Study of ShangRing Circumcision During Routine Clinical Services in Kenya and Zambia.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S18-23.
    PubMed     Text format     Abstract available


  339. AWORI QD, Lee RK, Li PS, Zulu R, et al
    Surgical Outcomes of Newly Trained ShangRing Circumcision Providers.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S13-7.
    PubMed     Text format     Abstract available


  340. SO-ARMAH KA, Tate JP, Chang CH, Butt AA, et al
    Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?
    J Acquir Immune Defic Syndr. 2016;72:206-213.
    PubMed     Text format     Abstract available


    May 2016
  341. BANGANI N, Nakiwala J, Martineau AR, Wilkinson RJ, et al
    HIV-1 infection impairs CD16 and CD35 mediated opsonophagocytosis of M.tuberculosis by human neutrophils.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  342. TABERNILLA A, Rego-Perez I, Grandal M, Pernas B, et al
    European Mitochondrial Haplogroups Impact on Liver Fibrosis Progression among HCV and HIV/HCV Coinfected Patients from Northwest Spain.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  343. CARRICO AW, Zepf R, Meanley S, Batchelder A, et al
    When the Party is Over: A Systematic Review of Behavioral Interventions for Substance-Using Men who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  344. MATHAD JS, Gupte N, Balagopal A, Asmuth D, et al
    Sex-related Differences in Inflammatory and Immune Activation Markers before and after combined Antiretroviral Therapy Initiation.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  345. MONROE AK, Lau B, Mugavero MJ, Mathews WC, et al
    Heavy Alcohol Use is Associated with Worse Retention in HIV Care.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  346. HUERGA H, Van Cutsem G, Ben Farhat J, Reid M, et al
    Who needs to be targeted for HIV testing and treatment in KwaZulu-Natal? Results from a population-based survey.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  347. TUFA DM, Ahmad F, Chatterjee D, Ahrenstorf G, et al
    HIV-1 infection results in increased frequency of active and inflammatory slanDCs that produce high level of IL-1beta.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  348. BERGIN P, Langat R, Omosa-Manyonyi G, Farah B, et al
    Assessment of anti-HIV-1 antibodies in Oral and Nasal Compartments of Volunteers from Three different Populations.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  349. ROBERTS ST, Haberer J, Celum C, Mugo N, et al
    Intimate partner violence and adherence to HIV pre-exposure prophylaxis (PrEP) in African women in HIV serodiscordant relationships: A prospective cohort study.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  350. WENDELKEN LA, Jahanshad N, Rosen HJ, Busovaca E, et al
    ApoE epsilon4 is Associated with Cognition, Brain Integrity and Atrophy in HIV Over Age 60.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  351. E-B ROSSHEIM A, Cunningham TD, Hair PS, Shah T, et al
    Effects of Well-Controlled HIV Infection on Complement Activation and Function.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  352. GALLANT J, Brunetta J, Crofoot G, Benson P, et al
    Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) in HIV-1/Hepatitis B Coinfected Adults.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  353. YAHYAEI S, Biasin M, Saulle I, Gnudi F, et al
    Identification of a Specific miRNA Profile in HIV Exposed Seronegative Individuals.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  354. MCHUGH G, Rylance J, Mujuru H, Nathoo K, et al
    Chronic morbidity among older children and adolescents at diagnosis of HIV infection.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  355. OKELLO S, Asiimwe SB, Kanyesigye M, Muyindike WR, et al
    D-dimer levels and traditional risk factors are associated with incident hypertension among HIV-infected individuals initiating antiretroviral therapy in Uganda.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  356. WEISS JJ, Konstantinidis I, Boueilh A, Fierer DS, et al
    Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults with HIV Infection and Hypertension or Chronic Kidney Disease.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  357. HERRIN M, Tate JP, Akgun KM, Butt AA, et al
    Weight Gain and Incident Diabetes among HIV Infected-Veterans Initiating Antiretroviral Therapy Compared to Uninfected Individuals.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  358. MACLENNAN CA, Richter A, Hodson J, Faustini S, et al
    Immunization of HIV-infected adults in the UK with Haemophilus influenzae b/meningococcal C glycoconjugate and pneumococcal polysaccharide vaccines.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  359. BEYMER MR, Weiss RE, Halkitis PN, Kapadia F, et al
    Disparities within the Disparity - Determining HIV Risk Factors among Latino Gay and Bisexual Men Attending a Community-Based Clinic in Los Angeles, California.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  360. RAMGOPAL M, Osiyemi O, Zorrilla C, Crauwels HM, et al
    Pharmacokinetics of Total and Unbound Etravirine in HIV-1-Infected Pregnant Women.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  361. ROY M, Muyindike W, Vijayan T, Kanyesigye M, et al
    Use of symptom screening and sputum microscopy testing for active tuberculosis case detection among HIV-infected patients in real-world clinical practice in Uganda.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  362. BRAUNSTEIN SL, Robertson MM, Myers J, Nash D, et al
    Using HIV Viral Load from Surveillance to Estimate the Timing of Antiretroviral Therapy Initiation.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  363. KNUDSEN A, Christensen TE, Thorsteinsson K, Ghotbi AA, et al
    Microbiota dependent marker TMAO is not associated with decreased myocardial perfusion in well-treated HIV-infected patients as assessed by 82Rubidium PET/CT.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  364. NICOL AF, Brunette LL, Nuovo GJ, Grinsztejn B, et al
    Secretory leukocyte protease inhibitor expression and high-risk HPV infection in anal lesions of HIV positive patients.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  365. EZEANOLUE EE, Nwizu C, Greene GS, Amusu O, et al
    Geographical Variation in Prevalence of Cryptococcal Antigenemia among HIV-infected Treatment-Naive Patients in Nigeria: A multicenter cross-sectional study.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  366. JAKUBOWSKI A, Omanga E, Agot K, Thirumurthy H, et al
    Large Price Premiums for Unprotected Sex Among Female Sex Workers in Kenya: A Potential Challenge for Behavioral HIV Prevention Interventions.
    J Acquir Immune Defic Syndr. 2016;72:e20-2.
    PubMed     Text format    


  367. LANZAFAME M, Gibellini D, Lattuada E, Signoretto C, et al
    Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load.
    J Acquir Immune Defic Syndr. 2016;72:e12-4.
    PubMed     Text format    


  368. LAMPKIN D, Crawley A, Lopez TP, Mejia CM, et al
    Reaching Suburban Men Who Have Sex With Men for STD and HIV Services Through Online Social Networking Outreach: A Public Health Approach.
    J Acquir Immune Defic Syndr. 2016;72:73-8.
    PubMed     Text format     Abstract available


  369. HARGREAVES JR, Mtetwa S, Davey C, Dirawo J, et al
    Implementation and Operational Research: Cohort Analysis of Program Data to Estimate HIV Incidence and Uptake of HIV-Related Services Among Female Sex Workers in Zimbabwe, 2009-2014.
    J Acquir Immune Defic Syndr. 2016;72:e1-8.
    PubMed     Text format     Abstract available


  370. TSUCHIYA K, Hayashida T, Hamada A, Oka S, et al
    Brief Report: High Peak Level of Plasma Raltegravir Concentration in Patients With ABCB1 and ABCG2 Genetic Variants.
    J Acquir Immune Defic Syndr. 2016;72:11-4.
    PubMed     Text format     Abstract available


    April 2016
  371. ALUISIO AR, Bosire R, Betz B, Gatuguta A, et al
    Male Partner Participation in Antenatal Clinic Services is Associated with Improved HIV-free survival Among Infants in Nairobi, Kenya: A Prospective Cohort Study.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  372. SMITH SJ, Pauly GT, Akram A, Melody K, et al
    Rilpivirine and Doravirine have complementary efficacies against NNRTI-Resistant HIV-1 mutants.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  373. ZUCCHETTO A, Virdone S, Taborelli M, Grande E, et al
    Non-AIDS Defining Cancer Mortality: Emerging Patterns in the Late HAART Era.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  374. BIENCZAK A, Denti P, Cook A, Wiesner L, et al
    Plasma efavirenz exposure, sex, and age predict virological response in HIV-infected African children.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  375. SUDFELD CR, Lei Q, Chinyanga Y, Tumbare E, et al
    Linear Growth Faltering Among HIV-Exposed Uninfected Children.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  376. OLSON AD, Walker AS, Suthar AB, Sabin C, et al
    Limiting Cumulative HIV Viremia Copy Years by Early Treatment Reduces Risk of AIDS and Death.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  377. KOETHE JR, Jenkins CA, Lau B, Shepherd BE, et al
    Higher Time-updated Body Mass Index: Association with Improved CD4+ Cell Recovery on HIV Treatment.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  378. TROY SB, E-B Rossheim A, Hilliard DD, Cunningham TD, et al
    Seroprevalence of Pertussis Infection in HIV-Infected Adults in the United States.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  379. MARKS G, Patel U, Stirratt MJ, Mugavero MJ, et al
    Single Viral Load Measurements Overestimate Stable Viral Suppression among HIV Patients in Care: Clinical and Public Health Implications.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  380. KALICHMAN SC, Kalichman MO, Cherry C, Eaton LA, et al
    Randomized Factorial Trial of Phone-Delivered Support Counseling and Daily Text Message Reminders for HIV Treatment Adherence.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  381. GOLDENBERG SM, Nguyen P, Muzaaya G, Akello M, et al
    War-related abduction and history of incarceration linked to high burden of HIV among female sex workers in conflict-affected Northern Uganda.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  382. MCCARTHY KM, Grant AD, Chihota V, Ginindza S, et al
    Implementation and Operational Research: What Happens After a Negative Test for Tuberculosis? Evaluating Adherence to TB Diagnostic Algorithms in South African Primary Health Clinics.
    J Acquir Immune Defic Syndr. 2016;71:e119-e126.
    PubMed     Text format     Abstract available


  383. LAUFER FN, Warren BL, Pulver WP, Smith LC, et al
    Return on Investment From Expenditures Incurred to Eliminate Mother-To-Child Transmission Among HIV-Infected Women in New York State: 1998-2013.
    J Acquir Immune Defic Syndr. 2016;71:558-62.
    PubMed     Text format     Abstract available


  384. GUO X, He S, Lv X, Ding H, et al
    The Role of HIV-1 in Affecting the Proliferation Ability of HPCs Derived From BM.
    J Acquir Immune Defic Syndr. 2016;71:467-73.
    PubMed     Text format     Abstract available


  385. MADLALA P, Singh R, An P, Werner L, et al
    Association of polymorphisms in the regulatory region of the cyclophilin A gene (PPIA) with gene expression and HIV/AIDS disease progression.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  386. JOTWANI V, Scherzer R, Estrella MM, Jacobson LP, et al
    Cumulative tenofovir disoproxil fumarate exposure is associated with biomarkers of tubular injury and fibrosis in HIV-infected men.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  387. RUSTAGI AS, Gimbel S, Nduati R, Cuembelo MF, et al
    Impact of a systems engineering intervention on PMTCT service delivery in Cote d'Ivoire, Kenya, Mozambique: a cluster randomized trial.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  388. LIVINGSTON EG, Huo Y, Patel K, Tuomala RE, et al
    Complications and route of delivery in a large cohort study of HIV-1-infected Women- IMPAACT P1025.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  389. LIPPMAN SA, Shade SB, El Ayadi AM, Gilvydis JM, et al
    Attrition and opportunities along the HIV care continuum: findings from a population-based sample, North West Province, South Africa.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  390. MUJUGIRA A, Celum C, Coombs RW, Campbell JD, et al
    HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  391. THORNHILL J, Inshaw J, Kaleebu P, Cooper D, et al
    Enhanced normalisation of CD4/CD8 ratio with earlier antiretroviral therapy at Primary HIV Infection.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  392. PETTIT AC, Mendes A, Jenkins C, Napravnik S, et al
    Timing of Antiretroviral Treatment, Immunovirologic Status and TB Risk: Implications for Test and Treat.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  393. PRESTAGE G, Brown G, Allan B, Ellard J, et al
    Impact of Peer Support on Behavior Change Among Newly Diagnosed Australian Gay Men.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  394. SHUPER PA, Pillay S, MacDonald S, Christie S, et al
    One in Four HIV-Positive South Africans Awaiting ART Initiation Report Condomless Sex with a Serodiscordant Partner.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  395. LEADER JK, Crothers K, Huang L, King MA, et al
    Risk Factors Associated With Quantitative Evidence of Lung Emphysema and Fibrosis in an HIV-Infected Cohort.
    J Acquir Immune Defic Syndr. 2016;71:420-7.
    PubMed     Text format     Abstract available


  396. ABUDULAI LN, Fernandez S, Corscadden K, Hunter M, et al
    Chronic HIV-1 Infection Induces B-Cell Dysfunction That Is Incompletely Resolved by Long-Term Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2016;71:381-9.
    PubMed     Text format     Abstract available


  397. MUGWANYA KK, Wyatt C, Celum C, Donnell D, et al
    Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis.
    J Acquir Immune Defic Syndr. 2016;71:374-80.
    PubMed     Text format     Abstract available


  398. ROXBY AC, Fredricks DN, Odem-Davis K, Asbjornsdottir K, et al
    Changes in Vaginal Microbiota and Immune Mediators in HIV-1-Seronegative Kenyan Women Initiating Depot Medroxyprogesterone Acetate.
    J Acquir Immune Defic Syndr. 2016;71:359-66.
    PubMed     Text format     Abstract available


  399. SAITO S, Mpofu P, Carter EJ, Diero L, et al
    Implementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012.
    J Acquir Immune Defic Syndr. 2016;71:e96-e106.
    PubMed     Text format     Abstract available


  400. HUERGA H, Mueller Y, Ferlazzo G, Mpala Q, et al
    Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings.
    J Acquir Immune Defic Syndr. 2016;71:e89-95.
    PubMed     Text format     Abstract available


    March 2016
  401. CHAN BT, Tsai AC
    Trends in HIV-related Stigma in the General Population During the Era of Antiretroviral Treatment Expansion: An Analysis of 31 Sub-Saharan African Countries.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  402. PURSWANI MU, Patel K, Winkler CA, Spector SA, et al
    APOL1 Renal Risk Variants are Associated with Chronic Kidney Disease in Children and Youth with Perinatal HIV infection.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  403. RAJCHGOT J, Siemieniuk RA, Sivachandran N, Murphy P, et al
    Feasibility of HIV Pre-Exposure Prophylaxis as part of routine care in Toronto, Canada.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  404. HAREL O, Nazzaro V
    Re-thinking data collection for HIV prevention trials.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  405. KEITH A, Dong Y, Shuter J, Himelhoch S, et al
    Behavioral Interventions for Tobacco Use in HIV-infected Smokers: A Meta-analysis.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  406. MARCUS JL, Chao CR, Leyden WA, Xu L, et al
    Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  407. XIA Q, Braunstein SL, Wiewel EW, Eavey JJ, et al
    Persons Living with HIV in the United States: Fewer Than We Thought.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  408. MAMAN S, Groves AK, McNaughton Reyes HL, Moodley D, et al
    Diagnosis and disclosure of HIV status: Implications for women's risk of physical partner violence in the postpartum period.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  409. JACOBSON KR, Arora S, Walsh KB, Lora M, et al
    High Feasibility of Empiric HIV Treatment for Patients with Suspected Acute HIV in an Emergency Department.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  410. JOHN M, Greene M, Hessol NA, Zepf R, et al
    Geriatric Assessments And Association With Vacs Index Among Hiv-Infected Older Adults In San Francisco.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  411. GUEUDIN M, Baron A, Alessandri-Gradt E, Lemee V, et al
    Performance Evaluation of the new HIV-1 quantification assay, Xpert(R) HIV-1 Viral Load, on a wide panel of HIV-1 variants.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  412. VASSENA L, Giuliani E, Rita Buonomini A, Malagnino V, et al
    L-Selectin (Cd62l) Is Downregulated On Cd4+ And Cd8+ T Lymphocytes Of Hiv-1-Infected Individuals NaIve For Art.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  413. LIU Y, Qian HZ, Ruan Y, Wu P, et al
    Frequent HIV Testing: Impact on HIV Risk Among Chinese Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  414. KHAITAN A, Kravietz A, Mwamzuka M, Marshed F, et al
    FOXP3+Helios+ regulatory T cells, immune activation and advancing disease in HIV infected children.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  415. KIRAGGA AN, Nalintya E, Morawski BM, Kigozi J, et al
    Impact of nurse-targeted care on HIV outcomes among immunocompromised persons: a before-after study in Uganda.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  416. YIN MT, Shiau S, Rimland D, Gibert CL, et al
    Fracture prediction with modified-FRAX in older HIV-infected and uninfected men.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  417. KIM HN, Nance R, Van Rompaey S, Delaney JC, et al
    Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  418. KANCHEVA LANDOLT N, Bunupuradah T, Kosalaraksa P, Ubolyam S, et al
    High variability of hormonal levels and no clinically relevant interaction between ethinyl estradiol, desogestrel and lopinavir/ritonavir in a small sample of HIV-positive adolescents.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  419. YENDE-ZUMA N, Naidoo K
    The effect of timing of initiation of ART on loss to follow up in HIV-TB co infected patients in South Africa: An open label randomized controlled trial.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  420. DIMITROV DT, MAsse BR, Donnell D
    PrEP adherence patterns strongly impact individual HIV risk and observed efficacy in randomized clinical trials.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  421. OKATCH H, Beiter K, Eby J, Chapman J, et al
    Brief Report: Apparent Antiretroviral Over-adherence by Pill Count is Associated with HIV Treatment Failure in Adolescents.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  422. HALL HI, Tang T, Satcher Johnson A, Espinoza L, et al
    Timing of linkage to care after HIV diagnosis and time to viral suppression.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  423. ROSS EL, Cinti SK, Hutton DW
    A cost-effective, clinically actionable strategy for targeting HIV preexposure prophylaxis to high-risk men who have sex with men.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  424. RITCHWOOD TD, Hughes JP, Jennings L, MacPhail C, et al
    Characteristics of Age-discordant Partnerships Associated with HIV Risk Among Young South African Women (HPTN 068).
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  425. FLEISHMAN JA, Monroe AK, Voss CC, Moore RD, et al
    Expenditures for Persons Living with HIV Enrolled in Medicaid, 2006-2010.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  426. SONG IH, Zong J, Borland J, Jerva F, et al
    The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  427. CASADO JL, Del Rey JM, Banon S, Santiuste C, et al
    Changes in kidney function and in the rate of tubular dysfunction after tenofovir withdrawal or continuation in HIV-infected patients.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  428. GARRETT NJ, Drain P, Werner L, Samsunder N, et al
    Diagnostic Accuracy of the Point-of-care Xpert(R) HIV-1 Viral Load Assay in a South African HIV clinic.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  429. ELLIOTT JC, Delker E, Wall MM, Feng T, et al
    The importance of context: Neighborhood drinking norms and heavy drinking among HIV patients.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  430. SHAW S, Amico KR
    Antiretroviral therapy adherence enhancing interventions for adolescents and young adults 13 to 24 years of age: A review of the evidence base.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  431. BARBEE LA, Tat S, Dhanireddy S, Marrazzo JM, et al
    Effectiveness and Patient Acceptability of a Sexually Transmitted Infection Self-testing Program in an HIV Care Setting.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  432. RAYMOND S, Nicot F, Saune K, Cazabat M, et al
    HIV-1 Tropism during Primary Infections in France: 1996-2014.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  433. PRICE JC, Seaberg EC, Phair JP, Witt MD, et al
    Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  434. DIRIX V, Schepers K, Massinga-Loembe M, Worodria W, et al
    Added value of long-term cytokine release assays to detect M. tuberculosis infection in HIV-infected subjects in Uganda.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  435. CHEN L, Mahapatra T, Fu G, Huang S, et al
    Male Clients of Male Sex Workers in China: An Ignored High-Risk Population.
    J Acquir Immune Defic Syndr. 2016;71:316-22.
    PubMed     Text format     Abstract available


  436. NOSTLINGER C, Platteau T, Bogner J, Buyze J, et al
    Implementation and Operational Research: Computer-Assisted Intervention for Safer Sex in HIV-Positive Men Having Sex With Men: Findings of a European Randomized Multi-Center Trial.
    J Acquir Immune Defic Syndr. 2016;71:e63-72.
    PubMed     Text format     Abstract available


  437. MIREMBE BG, Kelly CW, Mgodi N, Greenspan S, et al
    Bone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis.
    J Acquir Immune Defic Syndr. 2016;71:287-94.
    PubMed     Text format     Abstract available


    February 2016
  438. VALLABHANENI S, Longley N, Smith M, Smith R, et al
    Evaluation of a Public-sector, Provider-initiated Cryptococcal Antigen Screening and Treatment Program, Western Cape, South Africa.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  439. BALKUS JE, Brown E, Palanee T, Nair G, et al
    An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  440. TRAN AH, Best BM, Stek A, Wang J, et al
    Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  441. LUBELCHEK RJ, Fritz ML, Finnegan KJ, Trick WE, et al
    Use of a real-time alert system to identify and re-engage lost-to-care HIV patients.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  442. FRENCH AL, Hotton A, Young M, Nowicki M, et al
    Isolated Hepatitis B Core Antibody Status is not Associated with Accelerated Liver Disease Progression in HIV/Hepatitis C Coinfection.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  443. KATAGIRA W, Walter ND, den Boon S, Kalema N, et al
    Empiric TB treatment of severely ill patients with HIV and presumed pulmonary TB improves survival.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  444. MAGGIOLO F, Difilippo E, Valenti D, Ortega PS, et al
    NRTI sparing therapy in virologically controlled HIV-1 infected subjects. Results of a controlled, randomized trial (Probe).
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  445. TREASURE GC, Aga E, Bosch RJ, Mellors JW, et al
    Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  446. GUERRI-FERNANDEZ R, Molina D, Villar-Garcia J, Prieto-Alhambra D, et al
    HIV infection is associated with worse bone material properties, independently of bone mineral density.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  447. CERUTTI B, Bader J, Ehmer J, Pfeiffer K, et al
    Performance of risk-charts to guide targeted HIV viral load monitoring of ART: applying the method on the data from a multi-centre-study in rural Lesotho.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  448. ELUL B, Wools-Kaloustian KK, Wu Y, Musick BS, et al
    Untangling the relationship between antiretroviral therapy use and incident pregnancy: A marginal structural model analysis using data from 47,313 HIV-positive women in East Africa.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available



  449. When to monitor CD4 cell count and HIV RNA to reduce mortality and AIDS-defining illness in virologically suppressed HIV-positive persons on antiretroviral therapy in high-income countries: a prospective observational study.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  450. RAYMENT M, Bull L, Evans C, Rooney G, et al
    A successful strategy to reduce loss to follow-up in HIV outpatient care: experiences of a large, urban clinic in the United Kingdom.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  451. SIDDIQI AE, Hall HI, Hu X, Song R, et al
    Population-Based Estimates of Life Expectancy After HIV Diagnosis. United States 2008 - 2011.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  452. RIANGWIWAT T, Kohorn L, Chow DC, Souza S, et al
    CD4/CD8 Ratio Predicts Peripheral Fat in HIV-infected Population.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  453. PHILBIN MM, Tanner AE, DuVal A, Ellen JM, et al
    HIV testing, care referral and linkage to care intervals affect time to engagement in care for newly diagnosed HIV-infected adolescents in fifteen adolescent medicine clinics in the United States.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  454. TURAN B, Smith W, Cohen MH, Wilson TE, et al
    Mechanisms For The Negative Effects Of Internalized Hiv-Related Stigma On Art Adherence In Women: The Mediating Roles Of Social Isolation And Depression.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  455. RAMANATHAN S, Custodio JM, Wei X, Wang H, et al
    Pharmacokinetics of Co-formulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate following Switch from Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Healthy Subjects.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  456. VALCOUR VG, Rubin LH, Obasi MU, Maki PM, et al
    Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  457. LI X, Fan P, Jiang C, Ma T, et al
    High-frequency Illegitimate Strand-transfers of Nascent DNA Fragments during Reverse Transcription Result in Defective Retrovirus Genomes.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  458. KAMADA AJ, Bianco AM, Zupin L, Girardelli M, et al
    Protective role of BST2 polymorphisms in mother-to-child transmission of HIV-1 and adult AIDS progression.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  459. RUAN A, Tobin NH, Mulligan K, Rollie A, et al
    Macrophage Activation in HIV-infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  460. SO-ARMAH KA, Tate JP, Chang CH, Butt AA, et al
    Do Biomarkers Of Inflammation, Monocyte Activation And Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  461. KHOSROPOUR CM, Dombrowski JC, Swanson F, Kerani RP, et al
    Trends in serosorting and the association with HIV/STI risk over time among men who have sex with men (MSM).
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  462. FOGEL JM, Hudelson SE, Ou SS, Hart S, et al
    HIV drug resistance in adults failing early antiretroviral treatment: results from the HIV Prevention Trials Network 052 trial.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  463. RAMASWAMI R, Chia G, Dalla Pria A, Pinato D, et al
    The evolution of HIV associated lymphoma over three decades.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  464. KINAI E, Kato S, Hosokawa S, Sadatsuki M, et al
    High plasma concentrations of zidovudine (AZT) do not parallel intracellular concentrations of AZT-triphosphates in infants during prevention of mother-to-child HIV-1 transmission.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  465. CLUTTER DS, Fessel WJ, Rhee SY, Hurley LB, et al
    Response to Therapy in Antiretroviral Therapy-Naive Patients with Isolated Nonnucleoside Reverse-Transcriptase Inhibitor-Associated Transmitted Drug Resistance.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  466. STEINER RJ, Black V, Rees H, Schwartz SR, et al
    Low receipt and uptake of safer conception messages in routine HIV care: Findings from a prospective cohort of women living with HIV in South Africa.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  467. GIRARD A, Vergnon D, Depince-Berger AE, Roblin X, et al
    A high rate of beta7+ gut homing lymphocytes in HIV infected Immunogical Non Responders is associated with poor CD4 T cell recovery during suppressive HAART.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  468. YAPA HM, Boffito M, Pozniak A
    What Dose Of Rifabutin Is Recommended With Antiretroviral Therapy?
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  469. LANGE C, van Leth F, Sester M
    Viral Load and Risk of Tuberculosis in HIV Infection.
    J Acquir Immune Defic Syndr. 2016;71:e51-3.
    PubMed     Text format    


  470. NEWCOMB ME, Mongrella MC, Weis B, McMillen SJ, et al
    Partner Disclosure of PrEP Use and Undetectable Viral Load on Geosocial Networking Apps: Frequency of Disclosure and Decisions About Condomless Sex.
    J Acquir Immune Defic Syndr. 2016;71:200-6.
    PubMed     Text format     Abstract available


  471. KERZERHO J, McIlvaine EJ, Anthony P, Mack WJ, et al
    Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women.
    J Acquir Immune Defic Syndr. 2016;71:172-80.
    PubMed     Text format     Abstract available


  472. JACOBSON JM, Zheng L, Wilson CC, Tebas P, et al
    The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection.
    J Acquir Immune Defic Syndr. 2016;71:163-71.
    PubMed     Text format     Abstract available


    January 2016
  473. WOHL D, Oka S, Clumeck N, Clarke A, et al
    A Randomized, Double-Blind comparison of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil fumarate (TDF), each coformulated with Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for initial HIV-1 Treatment: Week 96 results.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  474. BHATTACHARYA D, Tseng CH, Tate JP, Lo Re V 3rd, et al
    Isolated Hepatitis B Core Antibody is Associated with Advanced Hepatic Fibrosis in HIV/HCV Infection but not in HIV infection alone.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  475. MILLER PE, Haberlen SA, Brown TT, Margolick JB, et al
    Intestinal Microbiota-Produced Trimethylamine-N-oxide and its Association with Coronary Stenosis and HIV Serostatus.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  476. HONGE BL, Andersen MN, Jespersen S, Medina C, et al
    Macrophage activation in HIV-2 infected patients is less affected by antiretroviral treatment - sCD163 in HIV-1, HIV-2 and HIV-1/2 dually infected patients.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  477. MOORE DM, Cui Z, Lachowsky N, Raymond HF, et al
    HIV community viral load and factors associated with elevated viremia among a community-based sample of men who have sex with men (MSM) in Vancouver, Canada.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  478. CLUVER LD, Orkin MF, Yakubovich AR, Sherr L, et al
    Combination social protection for reducing HIV-risk behavior amongst adolescents in South Africa.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  479. DAN JM, Massanella M, Smith DM, Spina CA, et al
    Effect of Cytomegalovirus and HIV Transcription on CD57 and PD-1 T cell expression during Suppressive ART.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  480. JACOBSON JM, Routy JP, Welles S, DeBenedette M, et al
    Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  481. LI Y, Xie J, Han Y, Wang H, et al
    Lamivudine monotherapy-based cART is efficacious for HBV treatment in HIV/HBV co-infection when baseline HBV DNA<20,000IU/ml.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  482. GAROFALO R, Hotton AL, Kuhns LM, Gratzer B, et al
    Incidence of HIV infection and Sexually Transmitted Infections and Related Risk Factors among Very Young Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  483. COSTENARO P, Massavon W, Lundin R, Nabachwa SM, et al
    Implementation and Operational Research: Implementation of the WHO 2011 Recommendations for Isoniazid Preventive Therapy (IPT) in Children Living With HIV/AIDS: A Ugandan Experience.
    J Acquir Immune Defic Syndr. 2016;71:e1-8.
    PubMed     Text format     Abstract available


  484. KURUC JD, Cope AB, Sampson LA, Gay CL, et al
    Ten Years of Screening and Testing for Acute HIV Infection in North Carolina.
    J Acquir Immune Defic Syndr. 2016;71:111-9.
    PubMed     Text format     Abstract available


  485. WOLFF M, Shepherd BE, Cortes C, Rebeiro P, et al
    Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America Network.
    J Acquir Immune Defic Syndr. 2016;71:102-10.
    PubMed     Text format     Abstract available


  486. DESCHAMPS MM, Metch B, Morgan CA, Zorilla CD, et al
    Feasibility of Identifying a Female Sex Worker Cohort at High Risk of HIV Infection in the Caribbean for HIV Vaccine Efficacy Trials: Longitudinal Results of HVTN 907.
    J Acquir Immune Defic Syndr. 2016;71:70-7.
    PubMed     Text format     Abstract available


  487. SLAMA L, Jacobson LP, Li X, Palella FJ Jr, et al
    Longitudinal Changes Over 10 Years in Free Testosterone Among HIV-Infected and HIV-Uninfected Men.
    J Acquir Immune Defic Syndr. 2016;71:57-64.
    PubMed     Text format     Abstract available


  488. BROWN LK, Kennard BD, Emslie GJ, Mayes TL, et al
    Effective Treatment of Depressive Disorders in Medical Clinics for Adolescents and Young Adults Living With HIV: A Controlled Trial.
    J Acquir Immune Defic Syndr. 2016;71:38-46.
    PubMed     Text format     Abstract available


  489. PARSONS MS, Madhavi V, Ana-Sosa-Batiz F, Center RJ, et al
    Brief Report: Seminal Plasma Anti-HIV Antibodies Trigger Antibody-dependent Cellular Cytotoxicity: Implications for HIV Transmission.
    J Acquir Immune Defic Syndr. 2016;71:17-23.
    PubMed     Text format     Abstract available


  490. JENSEN SS, Tingstedt JL, Larsen TK, Brandt L, et al
    HIV-Specific CD8+ T Cell-Mediated Viral Suppression Correlates With the Expression of CD57.
    J Acquir Immune Defic Syndr. 2016;71:8-16.
    PubMed     Text format     Abstract available


  491. HICKEY M, Marino JL, Tachedjian G
    Critical Review: Mechanisms of HIV Transmission in Depo-Provera Users: The Likely Role of Hypoestrogenism.
    J Acquir Immune Defic Syndr. 2016;71:1-7.
    PubMed     Text format     Abstract available


    December 2015
  492. MAZZAFERRI F, Cordioli M, Lattuada E, Veneri D, et al
    MONOCLONAL GAMMOPATHY IN HIV-INFECTED PATIENTS ON STABLE ANTIRETROVIRAL THERAPY: DISAPPEARANCE OR DEEP REDUCTION?
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format    


  493. BERTINE M, Visseaux B, Storto A, Collin G, et al
    HIV-2 Vif Diversity among Defective and non Defective Sequences.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format    


  494. BENDER IGNACIO RA, Lee JY, Rudek MA, Dittmer DP, et al
    A phase 1b/pharmacokinetic trial of PTC299, a novel post-transcriptional VEGF inhibitor, for AIDS-related Kaposi's sarcoma: AIDS Malignancy Consortium trial 059.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  495. RUONE S, Paxton L, McLaurin T, Taylor A, et al
    HIV-1 evolution in breakthrough infections in a human trial of oral pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil fumarate.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  496. MARCELLIN F, Demoulin B, Suzan-Monti M, Maradan G, et al
    Risk Factors for HCV Reinfection or Transmission in HIV-HCV Coinfected MSM (ANRS-VESPA2 French National Survey).
    J Acquir Immune Defic Syndr. 2015;70:e179-e182.
    PubMed     Text format    


  497. KAPLAN JE, Bateganya MH, Hamm TE, Langley C, et al
    Authors' Reply: Evidence-Based Programming of HIV Care and Support: Is the Psychosocial "Optional"?
    J Acquir Immune Defic Syndr. 2015;70:e178-e179.
    PubMed     Text format    


  498. BARBARA C, Mark N, Rachel M, Arvind K, et al
    Strengthening the "Viral Failure Pathway": Clinical Decision and Outcomes of Patients With Confirmed Viral Failure in a Large HIV Care Clinic in Uganda.
    J Acquir Immune Defic Syndr. 2015;70:e174-e176.
    PubMed     Text format    


  499. HODOWANEC A, Williams B, Hanson B, Livak B, et al
    Soluble CD163 But Not Soluble CD14 Is Associated With Cytomegalovirus Immunoglobulin G Antibody Levels in Virologically Suppressed HIV+ Individuals.
    J Acquir Immune Defic Syndr. 2015;70:e171-e174.
    PubMed     Text format    


  500. SCHWARCZ S, Hsu LC, Scheer S
    Disparities and Trends in Viral Suppression During a Transition to a "Test and Treat" Approach to the HIV Epidemic, San Francisco, 2008-2012.
    J Acquir Immune Defic Syndr. 2015;70:529-537.
    PubMed     Text format     Abstract available


  501. SIANGPHOE U, Archer KJ
    Gene Expression in HIV-Associated Neurocognitive Disorders: A Meta-Analysis.
    J Acquir Immune Defic Syndr. 2015;70:479-488.
    PubMed     Text format     Abstract available


  502. HE S, Zhang Z, Fu Y, Qin C, et al
    Thymic Function Is Most Severely Impaired in Chronic HIV-1 Infection, but Individuals With Faster Disease Progression During Early HIV-1 Infection Expressed Lower Levels of RTEs.
    J Acquir Immune Defic Syndr. 2015;70:472-478.
    PubMed     Text format     Abstract available


  503. HAIT SH, Soares EA, Sprinz E, Arthos J, et al
    Worldwide Genetic Features of HIV-1 Env alpha4beta7 Binding Motif: The Local Dissemination Impact of the LDI Tripeptide.
    J Acquir Immune Defic Syndr. 2015;70:463-471.
    PubMed     Text format     Abstract available


  504. KUEBLER PJ, Shaw BI, Leadabrand KS, Mehrotra ML, et al
    HIV-1 gp120 T cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemprophylaxis Trial.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  505. SANTOS GM, Coffin P, Santos D, Huffaker S, et al
    Feasibility, acceptability and tolerability of targeted naltrexone for non-dependent methamphetamine-using and binge-drinking men who have sex with men.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  506. HARGREAVES JR, Mtetwa S, Davey C, Dirawo J, et al
    Cohort analysis of programme data to estimate HIV incidence and uptake of HIV-related services among female sex workers in Zimbabwe, 2009-14.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  507. PATTACINI L, Baeten JM, Thomas KK, Fluharty TR, et al
    Regulatory T-cell activity but not conventional HIV-specific T-cell responses are associated with protection from HIV-1 infection.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  508. GALASKI J, Ahmad F, Tibroni N, Pujol FM, et al
    Cell Surface Downregulation of NK Cell Ligands by Patient-derived HIV-1 Vpu and Nef Alleles.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  509. D'SOUZA G, Wentz A, Wiley D, Shah N, et al
    Anal Cancer Screening in Men Who Have Sex with Men in the Multicenter AIDS Cohort Study.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  510. GOSWAMI ND, Schmitz MM, Sanchez T, Dasgupta S, et al
    Understanding Local Spatial Variation along the Care Continuum: The Potential Impact of Transportation Vulnerability on HIV Linkage to Care and Viral Suppression in High-Poverty Areas, Atlanta, Georgia.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  511. OLWENYI OA, Naluyima P, Cham F, Quinn TC, et al
    Differential associations of IL-6 and intestinal fatty acid-binding protein with progressive untreated HIV-1 infection in Rakai, Uganda.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


    November 2015
  512. POZNIAK A, Arribas JR, Gathe J, Gupta SK, et al
    Switching to tenofovir alafenamide, coformulated with elvitegravir, cobicistat, and emtricitabine, in HIV-infected patients with renal impairment: 48 week results from a single-arm, multi-center, open-label, Phase 3 study.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  513. BROWN B, LeComte-Hinely J, Brinkman D, MacCarthy S, et al
    Barriers to routine HIV testing in healthcare settings and potential solutions from the Get Tested Coachella Valley campaign.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format    


  514. YACOUB R, Nadkarni GN, Weikum D, Konstantinidis I, et al
    Elevations in Serum Creatinine with Tenofovir-Based HIV Pre-exposure Prophylaxis: A Meta-Analysis of Randomized Placebo-Controlled Trials.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format    


  515. BENGTSON AM, Chibwesha CJ, Westreich D, Mubiana-Mbewe M, et al
    Duration of cART before delivery and low infant birthweight among HIV-infected women in Lusaka, Zambia.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  516. SHIVE CL, Clagett B, McCausland MR, Mudd JC, et al
    Inflammation perturbs the IL-7 axis, promoting senescence and exhaustion that broadly characterize immune failure in treated HIV infection.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  517. MCCARTHY K, Grant AD, Chihota V, Ginindza S, et al
    What happens after a negative test for tuberculosis? Evaluating adherence to TB diagnostic algorithms in South African Primary Health Clinics.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  518. HORACIO RE, Itziar FL, Alla S, Nikita J, et al
    Nutritional and immunological correlates of memory and neurocognitive development among HIV infected children living in Kayunga, Uganda.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  519. VAN LUNZEN J, Pozniak A, Gatell JM, Antinori A, et al
    Switch to ritonavir-boosted atazanavir plus raltegravir in virologically suppressed patients with HIV-1 infection: a randomized pilot study.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  520. SABBAJ S, Scanlon N, Du VY, Wang Y, et al
    Enhanced allogeneic cellular responses to mismatched HLA-B antigens results in more efficient killing of HIV infected cells.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  521. ROSE KA, Vera JH, Drivas P, Banya W, et al
    Atherosclerosis is evident in treated HIV-infected subjects with low cardiovascular risk by carotid cardiovascular magnetic resonance.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  522. CHEN M, Jen I, Sharp GB, Arthur Chen YM, et al
    The Incidence Rates and Standardized Incidence Ratios of Cancer in Hemophilic HIV/AIDS Patients in Taiwan.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format    


  523. BUNGE KE, Dezzutti CS, Rohan LC, Hendrix CW, et al
    A Phase 1 trial to assess the safety, acceptability, pharmacokinetics and pharmacodynamics of a novel dapivirine vaginal film.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  524. HUERGA H, Mueller Y, Ferlazzo G, Mpala Q, et al
    Feasibility of using tuberculin skin test screening for initiation of 36-month isoniazid preventive therapy in HIV-infected patients in resource-constrained settings.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  525. SAITO S, Mpofu P, Carter EJ, Diero L, et al
    Declining Tuberculosis Incidence among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  526. MACURA SL, Lathrop MJ, Gui J, Doncel GF, et al
    BLOCKING CXCL9 DECREASES HIV-1 REPLICATION AND ENHANCES THE ACTIVITY OF PROPHYLACTIC ANTIRETROVIRALS IN HUMAN CERVICAL TISSUES.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  527. SUI Y, Lee EM, Wang Y, Hogg A, et al
    Early SIV dissemination after intra-rectal SIVmac251 challenge was associated with proliferating virus-susceptible cells in the colorectum.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  528. CORNELI A, Perry B, McKenna K, Agot K, et al
    Participants' explanations for non-adherence in the FEM-PrEP clinical trial.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  529. NOSTLINGER C, Platteau T, Bogner J, Buyze J, et al
    Computer-assisted Intervention for Safer Sex in HIV-Positive Men Having Sex with Men: Findings of a European Randomized Multi-Center Trial.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  530. BRUMMEL SS, Singh KK, Maihofer AX, Farhad M, et al
    Associations of Genetically Determined Continental Ancestry with CD4+ Count and Plasma HIV-1 RNA beyond Self-Reported Race and Ethnicity.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  531. BONACCI RA, Holtgrave DR
    Additional Indicators to Measure New HIV Diagnoses: A Response to Chow et al.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format    


  532. KELLY J, Wortley P, Drenzek C
    Veteran's Administration Care Continuum uses the wrong denominator.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format    


  533. HOENIGL M, Chaillon A, Moore DJ, Morris SR, et al
    Clear Links between Starting Methamphetamine and Increasing Sexual Risk Behavior: a cohort study among Men who have Sex with Men.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  534. WEISS L, Chevalier MF, Assoumou L, Paul JL, et al
    Rosuvastatin is effective to decrease CD8 T-cell activation only in HIV-infected patients with high residual T-cell activation under antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  535. ROSEN DL, Wohl DA, Golin CE, Rigdon J, et al
    Comparing HIV case detection in prison during opt-in vs. opt-out testing policies.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format    


  536. MYERS JE, Xia Q, Torian LV, Irvine M, et al
    CD4 Count Monitoring Frequency and Risk of CD4 Count Dropping Below 200 cells/mm3 Among Stable HIV-Infected Patients in New York City, 2007-2013.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


  537. MARCUS JL, Neugebauer RS, Leyden WA, Chao CR, et al
    Use of abacavir and risk of cardiovascular disease among HIV-infected individuals.
    J Acquir Immune Defic Syndr. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: